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CHAPTER 1 
Hypoxia-induced Damage to the Adult and Immature Brain: Molecular Mechanism 
of Oxidative Damage 
1 Neuropathology of Reperfusion Injury 
Brain ischemia/reperfusion results in extensive injury and is a substantial medical 
burden because of the ensuing morbidity and mortality.  In adults, ischemic insults to 
the brain typically result from stroke (caused by either thrombotic occlusion or rupture of 
a blood vessel) or cardiac arrest while, in infants, cerebral ischemia is initiated by 
complications during labor and delivery, resulting in neonatal hypoxic-ischemic 
encephalopathy.  In both cohorts, restoring blood flow and thus reestablishing nutrient 
and oxygen delivery to the ischemic brain will undoubtedly salvage neurons. However, 
reperfusion itself causes additional, substantial brain damage termed “reperfusion 
injury”.  The impact of cerebral ischemia/reperfusion injury on patient mortality is sizable 
irrespective of age or etiology. 
1.1 Stroke 
Stroke is the third leading cause of death and disability among Americans [1].  
Strokes are most commonly ischemic in origin, caused by vascular obstruction in the 
cerebral circulation.  If diagnosed in a timely manner, ischemic stroke can be reversed 
by administration of thrombolytic agents or, alternatively, the obstruction can be 
physically removed.  Neurons that lie distal to the obstructed vessel, relying exclusively 
on blood supply from this vessel, die from the prolonged complete ischemia.  These 
neurons comprise the infarcted region of the brain that is termed the “ischemic core”.  
Such neurons never regain function upon restoration of blood flow, and are dead prior 
to any window of therapeutic intervention.  Of greater clinical interest are the 
populations of neurons that die in a delayed manner after reperfusion is initiated.  These 
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neurons, surrounding the ischemic core - referred to as the “penumbra” - are in part 
perfused by collateral blood flow (i.e., are not fully reliant on blood flow from the 
obstructed vessel), and are therefore more resistant to ischemic damage.  Although 
neurons of the penumbra do not succumb to the initial ischemia-induced cell death, they 
go on to die during reperfusion in a delayed manner via mechanisms that resemble an 
apoptotic pathway.  The delay in death of these cells offers a window for therapeutic 
intervention, thus it is critical that treatment of the penumbra be considered prior to 
recanalization of the obstructed vessel.   
1.2 Cardiac Arrest/Resuscitation 
Another leading cause of brain ischemia/reperfusion injury is cardiac arrest 
followed by resuscitation.  In contrast to a focal brain insult caused by stroke, cardiac 
arrest results in complete ischemia throughout the entire brain.  The brain is an 
extremely sensitive organ, hence even short durations of global ischemia (beyond 10 
minutes) can result in debilitating neurologic deficits [2].  This sensitivity to ischemia 
may result from reliance on oxidative phosphorylation (OxPhos) for energy production, a 
concept we will address in detail in subsequent sections.   
Successful resuscitation can rapidly restore blood flow and oxygen delivery to the 
body, including the brain.  While approximately 70,000 patients are resuscitated from 
cardiac arrest each year, only ~10-35% of resuscitated patients survive to hospital 
discharge; this excessive death is likely a result of the severe brain damage caused by 
cerebral ischemia [2-4].  Whereas stroke results in a cerebral infarct, resuscitation from 
cardiac arrest results in neuronal death in select cell populations that are most sensitive 
to ischemic injury.  The most sensitive populations of neurons, the CA1 hippocampal 
neurons [5, 6], die during the first days of reperfusion [7, 8].  The specific biochemical 
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events that result in delayed neuronal death continue to be elucidated; however, 
overwhelming evidence has identified reactive oxygen species (ROS) generation as a 
key damaging event that leads to death of neurons [9-12].  
1.3 Neonatal Hypoxic-Ischemic Encephalopathy 
Ischemic insults to the infant brain cause hypoxic-ischemic encephalopathy 
(HIE), which leads to long-term neurocognitive deficits including cerebral palsy and 
epilepsy [13].  With an occurrence of approximately 2-4 per 1000 full-term in-hospital 
deliveries, HIE is a serious medical concern.  The consequences of HIE are more 
severe among low birth weight and premature newborns [14, 15].  Various antepartum 
causes of HIE have been identified including maternal hypotension and fetal growth 
restriction, yet, the most prevalent cause is prolapse or compression of the umbilical 
cord and placenta abruption [16-18].  There is extensive heterogeneity in 
neuropathology following HIE, primarily due to variation in the etiology and severity of 
the hypoxic/ischemic events [19].  However, as in the adult, reperfusion undoubtedly 
contributes significantly to the overall pathologic progression of HIE and thus is of 
therapeutic interest.    
2. A Mitochondrial Perspective on Reperfusion Injury 
Mitochondria have long been known to play a critical role in the pathogenesis of 
cerebral ischemia/reperfusion injury, via ROS generation, mitochondrial failure or 
dysfunction, and mitochondrial (type II) apoptosis.  In fact, during brain 
ischemia/reperfusion evidence exists for the three above deleterious events occurring 
within the mitochondria (see [20, 21]).  The goal of Chapter 1 is to present a hypothesis 
developed largely in the Sanderson and Hüttemann laboratories and propose a 
common link between the three above events in mitochondrial pathologies seen during 
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stroke, cardiac arrest, and HIE.  In Section 3 the hypothesis is extended to unify these 
three events into a novel paradigm that positions OxPhos as a central linchpin in the 
initiation and execution of cell death caused by ischemia/reperfusion.  However, before 
presenting this model of reperfusion injury, it is critical that we discuss: 1) how the 
OxPhos system functions; 2) the mechanism by which OxPhos generates and controls 
the mitochondrial membrane potential (∆Ψm); 3) control of OxPhos by phosphorylation; 
and finally 4) the role of the ∆Ψm in ROS generation.  
2.1 The Electron Transport Chain and Oxidative Phosphorylation  
The mitochondrial electrochemical gradient or protonmotive force (∆pm) is 
generated and utilized by the OxPhos system, composed of the electron transport chain 
(ETC) and ATP synthase.  A primary function of the ETC is to execute the transfer of 
electrons to the final electron acceptor, O2.  The molecular machinery that comprise the 
ETC include two major sites for electron entry, complex I (NADH dehydrogenase), and 
complex II (succinate dehydrogenase).  Electrons donated to either of these protein 
complexes are transferred to complex III (bc1 complex) via the non-protein electron 
carrier ubiquinone.  Electrons are transferred from complex III to complex IV 
(cytochrome c oxidase, CcO) via the electron carrier cytochrome c.   
CcO catalyses the final, and proposed rate limiting step in electron transfer; the 
donation of electrons to O2, allowing conversion of O2 and H+ to H2O.  The energy 
stored in the electrons is stepwise extracted by complexes I, III, and IV, which couple 
electron transfer along the ETC to pumping of H+ across the inner mitochondrial 
membrane.  This pumping of protons across the inner mitochondrial membrane 
constitutes the largest contributing force of the mitochondrial membrane potential 
(∆Ψm), representing the overall charge difference across the inner mitochondrial 
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membrane (see Section 2.2).  In addition, these chemical protons that are taken up from 
the matrix site contribute to the generation of ∆pm.  Finally, ∆pm is utilized by ATP 
synthase (complex V), which drives the conversion of ADP and Pi to ATP (Figure 1-1).  
This process provides the vast majority (90%) of ATP in the brain under normal 
conditions.  
Figure 1-1: The Mitochondrial Electron 
Transport Chain and Oxidative 
Phosphorylation. The mitochondrial OxPhos 
components include: complex I (NADH 
dehydrogenase), complex II (succinate 
dehydrogenase complex III (bc1 complex), 
complex IV (cytochrome c oxidase, CcO) and 
complex V (ATP synthase). Electrons donated to 
either complex I or complex II are transferred to 
complex III via the non-protein electron carrier 
ubiquinone. From there, electrons are transferred 
to complex via cytochrome c.  Electron flux 
through complexes I, III, and IV is couple to the 
pumping of H+ across the inner mitochondrial 
membrane. The generation of a proton gradient 
across the inner mitochondrial membrane drives 
the conversion of ADP and Pi to ATP by complex 
IV. 
 
Under non-stressed conditions, the transfer of electrons is a tightly regulated 
process. In fact, the vast majority of electrons that are donated to the ETC complete the 
entire reaction, culminating in reduction of O2.  However, a small percentage of 
electrons escape the ETC and can react with O2 to form superoxide (O2-), a potent ROS.  
The specific sites of ROS generation along the ETC are complexes I and III.  Although 
CcO (complex IV) produces several radical intermediates during the reduction of O2, no 
electrons are allowed to escape; as a result CcO does not directly produce ROS.  Under 
normal conditions, endogenous antioxidant systems are sufficient to scavenge the 
modest amounts of ROS generated and prevent cellular damage.  However, under 
pathologic conditions antioxidants become overwhelmed or exhausted, allowing the 
unopposed and uncontrolled production of ROS and resultant ROS-initiated damage to 
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cellular proteins, lipids, nucleic acids, and polysaccharides in an indiscriminate fashion 
[22-26].  To fully understand how ROS generation occurs and how this is controlled in a 
normal physiologic context, an appreciation of ∆pm and its primary component, the 
mitochondrial membrane potential ∆m, is required. 
2.2 The Proton Motive Force and Mitochondrial Membrane Potential 
∆pm consists of two components, 1) an electrical constituent, simply referred to as 
the mitochondrial membrane potential ∆Ψm, and 2) a chemical constituent, the pH 
difference across the inner mitochondrial membrane.  Their relationship is defined as 
∆pm = ∆Ψm - 59 ∆pH. The electrical component, ∆Ψm, represents the major portion of 
∆pm in higher organisms. 
In the traditional view, ∆pm (and ∆Ψm) are determined by two basic components, 
substrate availability and respiratory control, which both act on the OxPhos complexes.  
The most basic means of mitochondrial OxPhos regulation is dependent on both 
availability of substrate (e.g., NADH, O2, ADP, Pi) and its product, ATP.  ATP and ADP 
are allosteric inhibitors and activators of CcO, respectively, and this control mechanism 
was proposed to adjust ETC activity to energy demand [27, 28].  Another major OxPhos 
regulatory mechanism is provided by ∆pm itself, and is called respiratory control, as was 
demonstrated in isolated mitochondria more than five decades ago [29].  Respiratory 
control is a mechanism by which ∆pm causes inhibition of the ETC proton pumps when 
the proton gradient exceeds a threshold value, preventing further proton pumping at 
high ∆pm levels.  When ATP synthase converts ADP to ATP by utilizing the proton 
gradient, the reduction in ∆pm allows the proton pumps (i.e., complexes I, III, and IV) to 
resume electron transfer and to pump protons across the inner membrane.  In resting 
mitochondria, when the vast majority of ADP has been converted into ATP, synthesis of 
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ATP slows and ∆pm increases, inhibiting the proton pumps and thus mitochondrial 
respiration.  This feedback mechanism pairs the ETC activity to ∆m and serves to 
maintain ∆m at physiologic levels of 80-140mV - a range in which ATP production is 
efficient and ROS generation is minimal.   
Due to the difficulty of measuring absolute ∆pm in intact cells, most publications 
report ∆Ψm values, which constitute the majority of ∆pm.  ∆Ψm can be monitored in living 
cells using voltage-dependent fluorescent probes such as the rhodamine dye TMRE 
(tetramethyl-rhodamine ethyl ester), and changes in fluorescence indicate relative 
changes in ∆Ψm.  Absolute ∆Ψm levels in millivolts can also be determined in isolated 
mitochondria by measuring the distribution of a membrane permeable cation such as 
tetraphenylphosphonium (TPP) with a TPP-sensitive electrode.  In addition, absolute 
mV values for ∆Ψm can be determined in live cells by monitoring the redox states of the 
redox centers in bc1 complex, thus allowing the precise calculation of ∆Ψm [30]. 
Since ∆Ψm could be measured readily, studies investigating ∆Ψm revealed an 
important difference of ∆Ψm levels observed in isolated mitochondria versus intact cells.  
In isolated mammalian mitochondria from liver and brain under state 4 conditions, ∆Ψm 
values were measured ≥150 mV, often exceeding 200 mV [31-38].  In contrast, the 
majority of studies performed in a more physiological context with a variety of intact 
mammalian cells or even intact organs showed lower ∆Ψm values in the range of 80 to 
140 mV [39-43], with few studies reporting higher values between 140 – 161 mV [41, 
43-47].  This discrepancy may be explained by differences in the regulation of OxPhos 
activity in higher organisms.  
Respiratory control has traditionally been viewed as a key regulator of OxPhos.  
While this may be correct for OxPhos systems in bacteria, it appears that, in 
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eukaryotes, additional regulatory mechanisms are in place.  This idea is further 
supported by the fact that OxPhos enzymes are more complex in higher organisms.  
For example, CcO from bacteria contains 2 to 4 subunits whereas the mammalian 
enzyme is composed of 13 subunits per monomer and functions as a dimer, suggesting 
divergence with enhanced regulation [48, 49].  Although some differences between 
studies may be explained by different experimental conditions and the use of cells from 
different species and tissues, the emerging picture is that ∆Ψm values in isolated 
mitochondria are higher compared to those in intact cells.  Explanations for this 
discrepancy, and the consequences of high ∆Ψm values, will be discussed in the next 
two sections. 
2.3 OxPhos is Regulated by Reversible Phosphorylation 
Higher ∆Ψm values observed in isolated mitochondria compared to intact cells 
suggest that the isolation procedure per se may induce modifications resulting in 
readings above the true physiologic range.  Importantly, all mammalian OxPhos 
complexes are phosphorylated in vivo (reviewed in [50]), and we propose that these 
phosphorylations may be lost during traditional mitochondria isolation.  A recent study 
analyzing mitochondrial morphology and function showed that the structure of isolated 
mitochondria is clearly different compared to the morphology found in vivo [51].  The 
authors further demonstrated a ~2-fold increase in CcO activity.  Calcium is a buffer 
component used in some traditional protocols to purify mitochondria, and is a highly 
potent physiological second messenger and activator of mitochondrial function [52].  
Calcium was shown to trigger dephosphorylation of most mitochondrial proteins [53], 
which may be mediated by calcium-dependent phosphatases as the Hüttemann 
laboratory and others have postulated [50, 54, 55].  A similar scenario likely takes place 
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during ischemic stress, and this will be the focus of Section 3. 
The Hüttemann and Sanderson groups have proposed that phosphorylation of 
OxPhos complexes is a critical regulatory mechanism in higher organisms to maintain 
healthy respiration rates and to prevent hyperpolarization of ∆Ψm.  Using novel methods 
of mitochondrial and OxPhos protein isolation that preserve protein phosphorylation 
sites [56], cytochrome c and CcO were found to be reversibly phosphorylated at multiple 
residues [57-59].  Moreover, phosphorylation of these proteins altered their electron 
transfer kinetics and affected allosteric regulation by ATP and ADP [57].  
Phosphorylation of cytochrome c at either Tyr48 and Tyr97, caused reduced reaction 
rates with CcO, and is  proposed to lead to normal physiologic electron transfer rates 
[60-62].  In all tissue types investigated, cytochrome c was normally present in both the 
phosphorylated and dephosphorylated state.  Upon cellular stress (specifically, cerebral 
ischemia), the enzyme is rapidly dephosphorylated [63].  Interestingly, activation of cell 
signaling cascades that promote cell survival, such as insulin signaling [64], induce 
cytochrome c phosphorylation [63].  A residue on CcO was also identified that is 
reversibly phosphorylated (Tyr304), leading to inhibition of CcO [54].  Thus, 
dephosphorylation of CcO results in higher basal respiration. 
The hypothesis was further expanded to propose that mitochondrial isolation 
procedures or cellular stress, including ischemia, alter the physiological phosphorylation 
state of the OxPhos complexes.  This concept is supported by a study demonstrating 
hypoxia-induced changes in CcO phosphorylation in the heart [65].  In this model, 
phosphorylation of OxPhos proteins induce a healthy respiratory state where m 
values >140 mV inhibit further proton pumping, maintaining the 80-140 mV range where 
ROS production is minimal.  In contrast, cellular stress in vivo and isolation of 
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mitochondria in vitro causes changes and/or dephosphorylations of ETC complexes 
promoting maximal activity, and m only inhibits further proton pumping at very high 
∆Ψm values; thus, in this state m is hyperpolarized.  Support for the proposed  model 
is provided by studies showing that phosphorylation of CcO and cytochrome c, as found 
in vivo, leads to partial inhibition and thus healthy cell respiration [54, 60, 66].  
These studies demonstrate that stressful stimuli, such as ischemia, can result in 
changes in phosphorylation pattern of the OxPhos complexes, leading to ROS 
generation.  Conversely, survival signaling promotes phosphorylation and ‘controlled’ 
electron transfer rates.  Novel findings reported by Hüttemann et al. suggest a 
mechanism by which cell signaling cascades can regulate the overall basal activity rate 
of OxPhos [58].  Similar regulatory mechanisms may be discovered on other OxPhos 
complexes and functionally studied in the future.  It is our hypothesis that mitochondria 
in intact cells under healthy conditions do not function at maximal capacity.  This is 
reasonable because: 1) maximal rates of ATP synthesis by ATP synthase occur at 
∆Ψm=100-120 mV [67]; thus a further increase in ∆Ψm will not result in  more ATP 
production, and 2) as discussed in Section 2.4, high ∆Ψm levels cause excessive ROS 
production. 
2.4 Mitochondrial Membrane Potential Controls ROS Production 
Under normal conditions, over 90% of oxygen is fully reduced to H2O by CcO and 
only a small number of electrons ‘leak’ and lead to partial reduction of O2 to superoxide.  
This ROS production takes place proximal to CcO, at complexes I and III, which release 
superoxide on the matrix and intermembrane space sides, respectively [68].  In complex 
I, two major sites of electron escape have been proposed, the flavoprotein component 
of electron entry into complex I [69] or the iron-sulfur cluster [70].  For complex III, ROS 
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is produced by inhibition of electron transfer through the Q cycle [71].  Electron transfer 
from the cytochrome bL heme to the bH heme is inhibited at high ∆Ψm, resulting in 
ubisemiquinone radical generation [72].  Ubisemiquinone generated near the 
intermembrane space then reduces O2 to form superoxide.      
Electron leak occurs at complex I, complex III, or both, depending on the type of 
stressful stimuli and cell type, however one common mechanism exists.  It has been 
clearly demonstrated that ROS generation is dependent on ∆Ψm.  Specifically: 1) the 
maintenance of physiologically optimal ∆Ψm values, not exceeding 140 mV, prevents 
generation of ROS, while providing the full capability to produce ATP [67]; 2) although 
there are some conditions where ROS can be generated at low ∆Ψm levels through 
different mechanisms [73], it is generally accepted that pathophysiologic levels of ROS 
are produced at high ∆Ψm values; and 3) hyperpolarization of ∆Ψm (exceeding 140 mV) 
causes an exponential increase in ROS generation at both complexes I and III [71, 74-
76].  It was also shown that the ∆Ψm component alone, and not ∆pH of the proton 
motive force, determines ROS production at complex III [77].  High ∆Ψm levels extend 
the half-life of reaction intermediates of electron transfer at sites capable of single 
electron reduction of O2, thus allowing electron escape.   
Once partially reduced to superoxide, this oxygen radical reacts with other 
molecules such as H2O or H+ to generate even more reactive species H2O2, HO2, and 
OH.  In addition, superoxide interacts with NO to form equally cytotoxic reactive nitrogen 
species.  ROS generated in the mitochondria can freely cross mitochondrial membranes 
or exit via mitochondrial channels such as VDAC and, once released, can cause 
oxidative damage throughout the cell.  Of note, ROS react quickly (half-life of 
nanoseconds to seconds) and irreversibly to damage cell constituents.   
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An important question remains: why do mitochondria have an excess capacity to 
generate higher ∆Ψm levels with potentially disastrous consequences for the cell?  One 
reason is that mitochondria must have the capacity to adapt to varying energy 
demands.  However, a more plausible explanation is their involvement in mitochondrial 
(type II) apoptosis.  Numerous studies have demonstrated that induction of apoptosis, 
which is accompanied by stress signaling and can involve: 1) excessive calcium 
release; 2) transient hyperpolarization of ∆Ψm; and 3) a burst in the production of ROS, 
which has been proposed as a key signal for committing a cell to apoptosis (reviewed in 
[78]).  Accordingly, in Sections 3 and 4, this mitochondrial-centric sequence of events 
leading to cellular demise is integrated into a model of ischemia/reperfusion injury, and 
the concept that modulation of ∆Ψm may provide a novel strategy to attenuate brain 
damage caused by ischemia/reperfusion is discussed.    
3. Model of Ischemia/Reperfusion Injury  
The preceding sections have provided insight regarding the role of mitochondria in 
cell death caused by brain ischemia/reperfusion, and are consistent with a hypothesis 
that focuses on changes of the phosphorylation state of mitochondrial OxPhos and 
subsequent ∆Ψm hyperpolarization (Figure 1-2).  This model predicts that ischemic 
alterations of mitochondrial OxPhos primes the mitochondria for reperfusion-induced 
∆Ψm hyperpolarization, an associated burst in mitochondrial ROS generation and loss 
of mitochondrial function, and subsequent delayed neuronal death.  This progression is 
simplified into four main states that summarize the induction, progression, and 
execution of cell death during brain ischemia/reperfusion: 1) ischemic starvation; 2) 
reperfusion-induced hyperactivation; 3) mitochondrial dysfunction; and 4) delayed 
neuronal death (Figure 1-2).  
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Figure 1-2: Progression of Ischemia/reperfusion Injury. (A) Under normal, non-stressed conditions, 
OxPhos components are phosphorylated (as illustrated for cytochrome c and CcO), promoting controlled 
electron transfer and maintaining the ∆Ψm in the 80-140mV range.  This respiratory state is conducive to 
maximal ATP production and minimal ROS generation. (B) Ischemia induces a starvation state were the 
ETC cannot function due to lack of O2. Dephosphorylation of OxPhos during ischemia renders these 
enzymes ‘primed’ for hyperactivity, however they cannot operate due to lack of the terminal substrate for 
respiration, O2. (C) Reintroduction of O2 with reperfusion initiates electron transfer, proton pumping and 
ATP synthesis. However, in this hyperactive (dephosphorylated) state, OxPhos hyperpolarizes the ∆Ψm, 
causing an exponential increase in ROS generation at complexes I and/or III. (D) This burst in ROS can 
act as a signal for triggering apoptosis. In addition, damage caused by ROS induces a mitochondrial 
dysfunction state, with reduced electron transfer kinetics and reduced ∆Ψm levels, which results in 
energetic failure.   
 
3.1 Ischemic-Starvation State: Ischemic OxPhos Dephosphorylation and the Role 
of Calcium 
A unique feature of the brain is that it is almost exclusively dependent on 
oxidative phosphorylation to generate energy.  Therefore it is necessary to have a 
constant supply of oxygen to sustain functionality.  As discussed in previous sections, 
even under normal conditions, oxidative phosphorylation results in low-level production 
of ROS which immediately react with antioxidants and do not cause measurable cellular 
damage.  Brain ischemia of even short durations (on the order of seconds-minutes) 
causes cessation of electron transport, as OxPhos cannot proceed under anoxic 
conditions.  Electron stalling occurs when the rate of entry of electrons into complex I 
exceeds the rate of transit through the slowest step of the chain.  During ischemia, 
limiting electron transit through complex IV causes upstream build-up of electrons at 
complexes I and III, thus leading to reduced ETC.   
Without electron transfer and proton pumping across the inner mitochondrial 
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membrane, the proton gradient quickly dissipates, thereby disabling ∆pm-driven ATP 
generation by ATP synthase.  Ischemia has been found to cause depolarization of ∆Ψm 
following simulated ischemia in vitro [79] and in vivo during experimental stroke [80].  If 
ischemia persists, this eventually leads to ATP depletion and failure of all energy-
dependent processes in the mitochondria and throughout the cell [81, 82].  Depletion of 
ATP during ischemia would not allow ATP synthase to maintain ∆Ψm by operating in the 
reverse mode via ATP hydrolysis, a mechanism that operates under certain conditions 
such as in some cancer cells [83], where it is driven by high ATP flux through glycolysis.  
Of particular importance to ischemia/reperfusion injury is the equilibration of Ca2+ across 
the plasma membrane and subsequent accumulation of Ca2+ in the cytosol.  At high 
cytosolic [Ca2+], mitochondria actively sequester Ca2+ to prevent pathologic increases in 
cytosolic [Ca2+].  However, under the condition of ischemic depolarization, 
intramitochondrial [Ca2+] increases to pathologic levels with evidence (by electron 
microscopy) of severe mitochondrial swelling and accompanying hallmarks of cell death  
[84].  
Calcium is a potent activation signal for mitochondrial phosphatases.  For 
example, the calcium-dependent Ser/Thr-phosphatase, calcineurin, can 
dephosphorylate proteins within the mitochondria [85].  Indeed, Ca2+ accumulation in 
the mitochondria induces dephosphorylation of multiple mitochondrial proteins [53, 57].  
Moreover, it has been demonstrated that increased mitochondrial Ca2+ is a potent 
activation signal for mitochondrial respiration, leading to increased respiration and 
excessive ROS generation.  This scenario is consistent with that suggested by 
McCormack and Denton who postulated that the main role of increased mitochondrial 
Ca2+ is to stimulate ATP production by activating enzymes involved in metabolism [86].  
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The effect of Ca2+ on mitochondrial respiration does not appear to be due to a direct 
action of Ca2+ on ETC components, suggesting an intermediate step exists that could 
be activated by Ca2+.  The recent discoveries that dephosphorylation of CcO and 
cytochrome c lead to increased respiration rates provide a potential explanation for 
these early observations of the effect of Ca2+ on mitochondrial metabolism.   
The proposed model represents a pathologic alteration as a response to an 
imbalance between energy availability and energy demand.  Under conditions of mild 
hypoxia and inadequate ATP, energy demand would trigger Ca2+ signaling to increase 
mitochondrial respiration to increase ATP production in order to correct the deficiencies 
[87].  In contrast, under ischemic conditions, attempts to increase OxPhos activity in 
response to inadequate ATP are futile, as the final electron acceptor, O2, is not present.  
One can speculate that this feed-forward mechanism caused by ischemia would 
eventually promote maximal activation of OxPhos.  Indeed, others have questioned how 
a normal physiologic stimulus to increase energy production can lead to a pathologic 
increase in ROS generation [88].  When this process is viewed in the context of OxPhos 
dephosphorylation inducing subsequent hyperactivation of OxPhos, one can appreciate 
how ischemia could promote a mitochondrial state where substantial ROS can be 
generated upon reperfusion.   
3.2 Reperfusion-Induced Hyperactivation State: OxPhos Hyperactivity, ∆Ψm 
Hyperpolarization, and ROS Generation 
It is obvious that reperfusion of the ischemic brain is necessary for any attempt to 
salvage tissue.  However, as previously discussed, reperfusion per se contributes 
significantly to tissue damage.  From the perspective of ischemic mitochondria, 
reperfusion is necessary to restore the terminal substrate for OxPhos and nutrients to 
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reinitiate cellular respiration.  However, ischemia promotes a mitochondrial state that is 
conducive to hyperactive electron transfer upon reperfusion (Figure 1-3).  
 
Figure 1-3: Mechanism of ROS generation during reperfusion. During extended brain ischemia, 
increased intramitochondrial Ca2+ activates phosphatases that dephosphorylate OxPhos components, as 
shown for cytochrome c and CcO in B.  This promotes a state of OxPhos hyperactivity; however, because 
O2 is absent electron transport cannot proceed.  (C) Upon induction of reperfusion, OxPhos is allowed to 
operate at maximal activity, generating high ∆Ψm levels, which in turn promotes ROS generation.   
 
According to the proposed model, ischemia evokes an increase in 
intermitochondrial Ca2+ [84, 89, 90], causing activation of mitochondrial phosphatases 
and dephosphorylation of OxPhos complexes [53], most notably cytochrome c and CcO 
(Figure 1-3).  In addition to the effect on overall respiratory rate, dephosphorylation of 
CcO also leads to loss of allosteric inhibition by ATP [54, 55, 57, 60, 66].  Increased 
OxPhos activity alone could hyperpolarize ∆Ψm when reperfusion is initiated, and the 
loss of allosteric inhibition by ATP would further exacerbate this hyperpolarization.  This 
effect could essentially ‘reset’ respiratory control to a higher level, leading to loss of 
feedback inhibition between OxPhos and ∆Ψm at the normal 120-140mV range.  Under 
these conditions, hyperpolarization could be exacerbated and persist longer than 
otherwise possible without OxPhos dephosphorylation.   
Enhanced and prolonged ∆Ψm hyperpolarization would have dramatic 
consequences.  Liu et al. provided compelling evidence of  the exponential nature of the 
relationship between ROS and ∆Ψm (reviewed in [71]).  When ∆Ψm exceeds 140 mV the 
exponential nature becomes clear, resulting in a 70-90% increase in ROS generation 
with a modest 10 mV increase in ∆Ψm [71, 74].  Experimental measurements of ∆Ψm in 
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this elevated range are plausible.  In fact, as previously discussed, traditional 
mitochondrial isolation methods that do not take into account preservation of OxPhos 
phosphorylation often result in ∆Ψm above 200 mV [31-38].  These studies suggest that 
OxPhos dephosphorylation during ischemia would have profound consequences when 
reperfusion is initiated.   
During the initial moments of reperfusion, OxPhos dephosphorylation would 
serve to promote rapid reestablishment of ∆Ψm and restoration of cellular ATP levels.  
Indeed, following reversal of brain ischemia, ∆Ψm is restored to contol levels within 1 
minute, and cellular ATP levels are restored in less than 15 minutes [80].  However, if 
normal respiratory control mechanims are lost (including loss of alosteric inhibtion by 
ATP), ∆Ψm would  surpass normal levels, resulting in pathologic ∆Ψm hyperpolarization.  
In this regard, Liu et al. demonstrated that rapid restoration of ∆Ψm is quickly followed 
by hyperpolarization of ∆Ψm.  A study in neuronal cell culture exposed to simulated 
ischemia/reperfusion injury demonstrated ∆Ψm hyperpolaization during the initial 
reperfusion stages [91].  Moreover, inhibition of ∆Ψm hyperpolarization by blocking 
complex I has been shown to prevent a stress-induced ROS burst and subsequent cell 
death [92].  Finally, this concept was extended by Starkov and Fiskum, who reported 
that mitochondria isolated from brain do, indeed, have an exponential relationship 
between ∆Ψm and ROS when assayed in vitro [74].  These studies suggest a pathologic 
condition where reperfusion results in ∆Ψm hyperpolarization which subsequently 
causes a significant ROS burst upon reperfusion.   
Additional support for the OxPhos paradigm is provided by evidence 
demonstrating that the majority of ROS generation after brain ischemia occurs 
immediately upon reflow.  For example, in the setting of global brain ischemia, ROS 
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generation is most pronounced during the first 15 minutes of reperfusion [93].  
Moreover, the predominant source of these ROS are the mitochondrial OxPhos 
complexes [11, 94, 95] and, in brain, escape of electrons from complex I appears to be 
responsible for most of the ROS produced [95-98].   
As discussed in Section 2.4, the pivotal event that drives excessive electron 
escape and generation of ROS in vivo is ∆Ψm hyperpolarization.  These data imply that 
interventions aimed at regulating ∆Ψm and preventing hyperpolarization may serve to 
attenuate ROS generation.  Of particular interest is the dephosphorylation and 
hyperactivation of CcO, as CcO is the proposed rate-limiting step in OxPhos.  
Alternatively, direct targeting of ∆Ψm (for example, by using mitochondrial membrane 
uncoupling agents) may provide a feasible approach.  However, before considering 
modulation of ∆Ψm as a therapeutic strategy (see Section 4), the cytotoxic 
consequences of ROS generation are reviewed.   
3.3 Mitochondrial Dysfunction 
Early studies into mitochondrial function following brain ischemia/reperfusion 
injury found that, by 30 minutes of reperfusion, mitochondrial respiration is dramatically 
decreased in cell populations that are destined to die [99, 100].  More recent reports 
have demonstrated that global brain ischemia/reperfusion leads to a reduction in 
complex I and CcO activity at later stages of reperfusion.  This respiratory inhibition 
occurs within the first hour of reperfusion for CcO, and progresses more slowly for 
complex I (i.e., maximal inhibition by 24 hours of reperfusion [101]).  This loss of 
respiratory function is accompanied by a reduction and eventual collapse of ∆Ψm, 
leading to cell death.  Interestingly, while traditional studies have demonstrated reduced 
OxPhos activity during later reperfusion, recent evidence by Chomova and colleagues 
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has shown that, in the early minutes of reflow, OxPhos activities are increased over 
control levels [102].  These studies suggest that our current understanding of the 
responses of OxPhos to ischemia/reperfusion may be confounded by inappropriate 
mitochondrial extraction techniques employed in older reports.   
Mitochondrial dysfunction during reperfusion has often been attributed to ROS-
induced damage of mitochondrial components [70, 103].  The resulting OxPhos hypo-
activation state (Figure 1-2) results in impaired proton pumping and reduced electron 
transfer kinetics.  The mitochondrial switch from a hyperactive to dysfunctional 
hypoactive state has been attributed to oxidative damage of OxPhos complexes and/or 
oxidative damage to lipids important to OxPhos function.  In support of this concept, 
direct oxidative damage of mitochondria has been shown to be involved in cellular 
damage following brain ischemia/reperfusion [104, 105].  
A critical mitochondrial lipid target of ROS damage is cardiolipin.  This is a unique 
phospholipid in that the majority of cardiolipin is found in the inner mitochondrial 
membrane where it is in tight association with OxPhos components.  Cardiolipin plays a 
critical role in membrane insertion and function of cytochrome c, CcO, and other 
OxPhos complexes [106, 107], and there is growing evidence that cardiolipin plays a 
pivotal role in the regulation of mitochondrial bioenergetics [108, 109].  In fact, 
alterations in the structure and/or content of this phospholipid are responsible for 
mitochondrial dysfunction in a variety of pathological settings [110-113].  This concept is 
illustrated by the fact that disruption in the association of CcO with cardiolipin was 
accompanied by a ~50% reduction in activity of the enzyme [109].  Upon peroxidation, 
cardiolipin undergoes redistribution to the outer mitochondrial membrane [114] where it 
is required for release of apoptotic proteins from mitochondria into the cytosol [115].  
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These effects could contribute to decreased CcO activity, impaired mitochondrial 
respiration, and mitochondrial failure.   
Eventually, these pathologic alterations in mitochondrial function affect cellular 
functions and ultimately lead to cell death.  Alterations in mitochondrial function are 
potent signals for induction of cell death cascades.  Additionally, ROS have been 
implicated in directly activating cell death cascades.  For example, under conditions of 
persistent impaired respiration, mitochondrial (type II) apoptosis is induced, with the 
release of apoptogenic factors (including cytochrome c) from the mitochondria 
purportedly serving as the final and irreversible trigger of neuronal death.   
3.4 Delayed Neuronal Death: An Apoptotic-Like Phenotype 
Cell death is often classified as apoptotic or necrotic, however, following cerebral 
ischemia/reperfusion, cell death often proceeds in a manner distinct from traditional 
apoptosis or necrosis.  Morphologic and biochemical analysis indicate that both necrotic 
and apoptotic events occur simultaneously [84, 116], and evidence linking various 
pathways suggests that a degree of crosstalk exists that results in cell death occurring 
in a spectrum between apoptosis and necrosis [117].  The most common form of 
delayed, ischemia/reperfusion-induced neuronal cell death, and the type of insult that is 
the focus of the mechanism detailed in this Chapter, is characterized by an apoptotic-
like phenotype.  While all the specific characteristics of apoptosis may not be present, a 
key step – specifically, the release of apoptogenic factors from the mitochondria – 
appears critical in the initiation of cell death cascades [64, 118-120].   
Many mechanisms have been proposed to explain the release of cytochrome c 
from mitochondria.  Historically, it was hypothesized that mitochondria simply swell and 
burst, thereby releasing their contents into the cytosol.  More recently, a large body of 
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work has focused on the Bcl-2 family of proteins and their interactions as important 
regulators of mitochondrial permeability to cytochrome c.  Of the Bcl-2 family, the 
primary candidates proposed to be involved in outer membrane permeabilization appear 
to be Bax and Bak; these proteins purportedly interact directly with mitochondria to 
promote the release of cytochrome c and other apoptogenic proteins (e.g. AIF, 
Smac/Diablo) [121, 122].  In addition, other investigators have focused on elucidating 
the formation of so-called ‘permeability transition pores’ that would facilitate cytochrome 
c release. 
The caveat in all of these studies is that they are based on the premise that 
cytochrome c and other apoptogenic proteins are free within the mitochondria and, thus, 
could be released after pore formation or alterations in mitochondrial permeability.  
However, there is evidence that release of cytochrome c is a two-step process, 
involving 1) the release of proteins usually tethered to inner membrane by cardiolipin,  
combined with 2) pore formation [123].  Indeed, cytochrome c is among the proteins 
shown to be tethered to the inner mitochondrial membrane by cardiolipin [115, 124].  
Exposure of mitochondria to ROS induces peroxidation followed by oxidation of 
cardiolipin, thereby releasing cytochrome c into the intermitochondrial space [123].  
Subsequently, upon pore formation or alterations in permeability, the liberated 
cytochrome c is free to be released into the cytosol where it promotes formation of the 
apoptosome (a complex containing cytochrome c, caspase 9, and Apaf-1) that activates 
caspase 3.  The apoptotic pathways activated following ischemia/reperfusion converge 
on caspase-3, the downstream cysteine protease, leading to the cleavage of hundreds 
of potential substrates within the brain and thus executing programmed cell death [125].  
Indeed, activation of caspase-3, -8, and -9 have all been demonstrated to increase in 
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the brain following ischemia/reperfusion [116, 126-128].   
The aforementioned sequence of events identify multiple points of possible 
therapeutic intervention that, if appropriately targeted, could stop the progression of 
delayed neuronal cell death and thereby salvage tissue from ischemia/reperfusion 
injury.  For example, intervening at the level of apoptosis (including prevention of 
mitochondrial outer membrane pore formation, cardiolipin peroxidation, or caspase 
activation), should have therapeutic benefits.  However, attempts to prevent apoptotic 
cell death have revealed that multiple concurrent and redundant cell death pathways 
can be activated, making specific targeting of individual mediators or single pathways of 
apoptosis difficult or ineffective.  Therefore, a focus on upstream targets (that is, 
molecular events that precede cytochrome c release) may yield a more logical and 
robust therapeutic approach to neuroprotection.  
4. Intervention at OxPhos or ∆Ψm as a Potent Method of Neuroprotection 
Targeting ROS to reduce or prevent brain ischemia/reperfusion injury is one 
potential strategy to target an early cell death signal.  However, this method has been 
met with numerous clinical failures [129].  To understand this seemingly surprising lack 
of success, the traditional methodology for treatment of oxidative damage must be 
taken into consideration.   
Current studies have shown that during reperfusion, ROS production exceeds 
the availability of endogenous antioxidants.  Accordingly, previous attempts to design 
treatment modalities have focused on bolstering cellular antioxidant defenses to correct 
this imbalance.  This strategy is primarily based on laboratory studies demonstrating 
robust neuroprotection in transgenic animals designed to overexpress endogenous 
mitochondrial antioxidants [104, 130-132].  These studies have provided substantial 
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mechanistic insight into the pivotal role of ROS in cerebral ischemia/reperfusion injury.  
However, attempts to translate this concept and administer ROS scavengers as a 
clinical therapy have been futile [129].  This discrepancy could be explained by the 
multitude of potential pitfalls inherent in delivery of pharmacologic scavengers and 
antioxidants to the  brain during reperfusion, including difficulties in delivery, rapid 
reaction kinetics due to the short half-life of ROS, multiple ROS generation sites, limited 
cellular drug uptake, and failure to cross the blood-brain barrier [133, 134].  Despite 
improvements in drug formulation and delivery, the efficacy of antioxidant strategies 
seen in animal studies has, nonetheless, not been realized in human trials [135-138].   
As an alternative to this antioxidant approach, a cornerstone of the paradigm 
proposed by the Hüttemann and Sanderson labs is that interventions designed to 
prevent ROS generation (rather than scavenge ROS) will avoid many of the 
confounding issues associated with traditional scavenging techniques.  In this regard, 
hyperpolarization of ∆Ψm is a critical regulatory step in multiple pathologies, including 
early reperfusion of multiple tissues [74, 80, 139].  Moreover, targeting of 
hyperpolarization has been shown to be a cytoprotective [91, 140, 141].  
4.1 Uncoupling of Mitochondrial Membrane Potential 
Cells express mitochondrial proteins, i.e., uncoupling proteins (UCPs) that allow 
H+ to cross the inner mitochondrial membrane down the proton gradient.  This bypasses 
ATP synthase and thus does not produce ATP by utilizing the proton gradient.  The 
physiologic role of these proton channels is typically associated with heat generation.  
Recent studies have, however, found that UCPs have additional functions in the cell, 
including stabilizing the ∆Ψm, thereby limiting electron escape and thus partial reduction 
of O2 [75].  Interestingly, when UCPs were investigated in tissues where heat 
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generation is not a primary function (such as brain), it was found that these proteins 
render the brain resistant to ischemia/reperfusion injury.  For example, Haines et al. 
demonstrated that knockout of uncoupling protein 2 (UCP2) resulted in dramatically 
larger infarcts after stroke [142].  The converse was also true: overexpression of UCP2 
was associated with a decrease in ischemia/reperfusion-induced brain damage, ROS 
generation, and induction of apoptosis after stroke [143].  Finally, pivotal data from 
Teshima et al. demonstrated that increased expression of UCP2 prevented ROS-
induced cell death by stabilizing ∆Ψm [144].  These findings suggest that uncoupling 
proteins may play an important role in mitochondria by stabilizing ∆Ψm to prevent 
hyperpolarization and ROS production under stress.  As a result, these proteins may 
represent a potent target for therapeutic intervention.   
In addition to the use of UCPs to stabilize the ∆Ψm, exogenous chemicals that 
allow protons to cross the inner mitochondrial membrane have also been tested to 
prevent ischemia/reperfusion injury.  Proton ionophores (agents that allow proton leak 
across the inner membrane), have been shown to be effective in multiple disease 
states.  For example, mild mitochondrial membrane uncoupling reduced ∆Ψm 
hyperpolarization, prevented ROS, and reduced cell death in models of myocardial 
ischemia [141], traumatic brain injury [140], and peroxide-induced neuronal damage 
[92]. 
It is important to note that small concentrations of mitochondrial membrane 
uncoupling agents are profoundly protective whereas, in contrast, higher concentrations 
exacerbate cellular damage [145].  These studies are consistent with the proposed 
mechanism of ischemia/reperfusion injury discussed in this Chapter: mild membrane 
uncoupling will prevent the hyperpolarization of ∆Ψm during stressful conditions, while 
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complete uncoupling would allow excessive proton escape across the inner membrane 
and result in an energetic crisis.  This biphasic effect makes the use of these 
compounds potentially dangerous, as overdose of an uncoupling agent could 
dramatically compromise the ability to produce energy through OxPhos.  These 
compounds would also need to be present in the mitochondria during the time window 
of ∆Ψm hyperpolarization.  As the majority of studies suggest that this phenomenon 
occurs during the early seconds-minutes of reperfusion [93], delivery to tissue prior to 
reperfusion may pose a therapeutic barrier.  However, as discussed in the following 
section, there are potential methods capable of attenuating ∆Ψm hyperpolarization that 
do not require pharmacologic delivery.   
4.2 Ischemic Preconditioning  
Ischemic preconditioning is a phenomenon in which transient resistance to an 
ischemic insult is conferred to a tissue following brief episodes of sub-lethal ischemia.  
To investigate the effect of ischemic preconditioning on ∆Ψm, Liu and Murphy utilized a 
customized laser scanning confocal microscope together with ∆Ψm-specific fluorescent 
probes for real-time analysis of ∆Ψm in a mouse model of stroke [80].  The authors 
found that hyperpolarization of ∆Ψm was evident immediately following reflow, and that 
application ischemic preconditioning prevented ∆Ψm hyperpolarization and dramatically 
reduced the extent of neurologic injury.   
Of specific interest is the mechanism by which preconditioning can prevent ∆Ψm 
hyperpolarization at the onset of reperfusion.  Dave et al. demonstrated that brief 
episodes of antecedent preconditioning ischemia triggered the activation of PKC and 
upregulated mitochondrial survival signaling [146].  Preconditioning applied prior to 
global brain ischemia provided multiple beneficial effects to the mitochondria, including 
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phosphorylation of multiple OxPhos complexes, reduction of ROS generation, 
preservation of mitochondrial respiration during late reperfusion (the mitochondrial 
dysfunction phase) – events that culminated in decreased cytochrome c release, the 
putative trigger for apoptosis [146].  One could postulate that stimulation of cell signaling 
pathways that enhance phosphorylation of OxPhos complexes and limit cytochrome c 
release could promote controlled respiration and stabilize ∆Ψm.  Alternatively, a sub-
lethal ischemic event could induce OxPhos dephosphorylation on a small scale, 
generate small amounts of ROS, and thereby stimulate survival signaling responsible 
for maintaining phosphorylation.  If the activation of these kinases were increased 
during the subsequent ‘lethal’ ischemic event, this could provide protection from ∆Ψm 
hyperpolarization and ROS generation.  In addition, preconditioning could induce the 
expression of UCPs, thereby maintaining lower basal ∆Ψm levels and limiting 
hyperpolarization.  Indeed, Liu et al. demonstrated that preconditioning does increase 
UCP2 expression in brain [147].  However, whether this increase in expression in UCP2 
contributes to preconditioning-induced neuroprotection – and, the precise mechanism 
by which preconditioning modulates ∆Ψm – remains unknown.  
4.3 Induction of Cell Signaling to Induce OxPhos Phosphorylation 
Our current knowledge of cytochrome c and CcO suggests that the primary role 
of the phosphorylation sites discovered to date is to sustain controlled respiratory rates 
and thereby prevent ∆Ψm hyperpolarization and ROS generation [54, 60, 62, 63, 66, 
148].  Accordingly, it stands to reason that induction of cell signaling cascades that 
induce phosphorylation or prevent dephosphorylation would provide some protective 
effect.  Evidence from our group has shown that phosphorylation of cytochrome c at 
Tyr97 can be induced by insulin [63].  Moreover, insulin treatment was found to be 
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neuroprotective in a model of global brain ischemia/reperfusion by preventing the 
release of cytochrome c from mitochondria and inducing the upregulation of PI3K and 
other cell survival signaling cascades [64, 149].  Whether phosphorylation of 
cytochrome c at Tyr97 contributes to insulin-induced neuroprotection by stabilizing ∆Ψm 
is a focus of current investigation by our group.   
5. Conclusions 
This Chapter presents an overarching, mitochondrial-centric hypothesis 
describing the mechanisms that underlie mitochondrial ROS generation and cell death 
induced by reperfusion of ischemic brain tissue.  There is evidence to support this injury 
mechanism in multiple scenarios of cerebral ischemia/reperfusion injury including 
stroke, cardiac arrest followed by resuscitation, and hypoxic-ischemic damage.  The 
crux of the hypothesis is that ∆Ψm hyperpolarization and the ensuing ROS burst cause 
oxidative damage that precedes apoptosis in these pathologies.  Specifically, our group 
has proposed that: 1) ischemia induces dephosphorylation of OxPhos, thereby 2) 
priming the mitochondria for hyperactive electron transport and ∆Ψm hyperpolarization 
upon reperfusion, 3) initiating a burst of ROS which overwhelms endogenous 
antioxidant systems that 4), damages cellular components and 5) culminates in the 
initiation of apoptotic-like cell death cascades.  Most notably, this paradigm suggests 
that stabilization of ∆Ψm during early reperfusion provides a novel strategy to limit ROS 
generation and attenuate ischemia/reperfusion induced to brain.  
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CHAPTER 2 
Infrared Light Therapy: a Novel Approach for Attenuating Cerebral Reperfusion 
Injury 
1. Rationale 
Cerebral ischemia, sustained after cardiac arrest, is a major cause of death and 
disability [1-4].  Similarly, hypoxic events encountered during the perinatal period 
leading to pathologic decreases in fetal cerebral oxygen availability are detrimental 
resulting in neonatal hypoxic-ischemic encephalopathy (HIE) [13-15].  The current and 
only established and approved treatment to limit tissue damage and improve outcome 
after cerebral ischemia is prompt restoration of blood flow to the ischemic areas [150].  
However (and as discussed in Chapter 1), while timely reflow is essential for the 
salvage of ischemic neurons, reperfusion can promote ROS production and lead to 
significant, irreversible tissue damage as a result of resuscitation/reoxygentation [151].  
Many pharmacologic approaches have aimed at attenuating reperfusion injury by 
ROS scavenging.  However, this approach has yielded inconsistent results in 
experimental models and failed to translate into the clinic, possibly due to the intrinsic 
impediments in delivering adequate concentrations of scavengers to the subcellular 
site(s) within the crucial early seconds-minutes of reflow.  Thus, ongoing work in our 
laboratory, and by others, seeks to address this unmet need for an effective treatment 
of reperfusion injury by examining the preclinical efficacy of a novel non-invasive 
method.  This approach relies on the ability of infrared light (IRL) to attenuate the 
production of (rather than scavenging) ROS.  Unlike ultraviolet and visual light, IRL 
within the range of 700-1000nm readily passes through biological tissues [152, 153] and 
thus circumvents a major inherent limitation of traditional pharmacology-based 
treatments of reperfusion injury. 
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Figure 2-1: Modulation of CcO activity by IRL.
Percent change in the activity of isolated bovine CcO
in response to various IRL wavelengths alone or in
combination is shown  Data were obtained after 3 min
of irradiation using low-power diodes and activities
were normalized to non-irradiated samples. IRL with
a wavelength of 750nm or 950nm attenuated CcO
activity, and this effect is exaggerated when used in
combination. In contrast, IRL with a wavelength of
810nm modestly increased CcO activity. From
Hüttemann. 
1.1 Non-invasive Modulation of Mitochondrial Activity Using Infrared Light 
The concept that IRL may be of therapeutic benefit and modulate mitochondrial 
function is not entirely new, and previous studies have used IRL as a non-invasive 
therapy [154-160].  Efficacy has been demonstrated for multiple pathologies including 
nerve regeneration, peripheral neuropathy, stroke, and wound healing [156, 161-169]; 
however, results have often been contradictory likely owing to an incomplete 
understanding of IRL’s mechanism of action[170-173]. 
Work form the Hüttemann laboratory has demonstrated that IRL can directly 
modulate cytochrome c oxidase (CcO) activity in vitro (Figure 2-1).  This tendency for 
photobiomodulation of CcO activity likely stems from the various heme and copper 
centers within the enzyme.  These 
centers are influenced by light and 
directly modulate enzyme function [174, 
175]. IRL with a wavelength of 750nm or 
950nm was found to attenuate CcO 
activity, and this effect is exaggerated 
when used in combination.  In contrast, 
IRL with a wavelength of 810nm 
modestly increased CcO activity, 
consistent with previous reports 
examining this IRL wavelength [156, 
160]. 
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1.2 IRL Attenuates Mitochondrial Membrane Hyperpolarization and ROS 
Production In Vitro 
As introduced in Chapter 1 of this dissertation, the primary function of the 
mitochondrial ETC is to execute the transfer of electrons to O2.  CcO catalyses the last, 
and proposed rate limiting step in this process; the donation of electrons to O2, allowing 
conversion of O2 and H+ to H2O.  Electron flux through complexes I, III, and IV, is 
coupled to pumping of H+ across the inner mitochondrial membrane.  This pumping of 
protons across the inner mitochondrial membrane constitutes the largest contributing 
force of the mitochondrial membrane potential (∆Ψm), which represents the overall 
charge difference across the inner mitochondrial membrane.  During reperfusion, 
increases in ∆Ψm are believed to contribute to the generation of mitochondrial ROS.  
Thus, modulation of CcO activity via irradiation with IRL may provide a direct means of 
controlling ∆Ψm (and in turn ROS production) non-invasively.  
Using live-cell imaging in conjunction with the ∆Ψm-specific fluorescent probe, 
TMRM, the Sanderson laboratory observed that IRL irradiation with a wavelength of 
950nm decreased ∆Ψm which quickly returned to control levels when irradiation was 
discontinued (Figure 2-2 A).  These results indirectly demonstrate the ability the 950 nm 
wavelength of IRL to suppress ETC electron flux via its inhibitory effect on CcO.  Using 
this in vitro method, the effect of IRL irradiation during simulated ischemia-reperfusion 
was examined using immortalized hippocampal neurons (HT22 cells).  These studies 
confirmed the hyperpolarization of ∆Ψm during the first 30 minutes of reoxygenation, as 
predicted by the mechanism proposed above (Figure 2-2 B).  Furthermore, as shown in 
Figure 2-2 B, IRL irradiation with a wavelength of 950nm during the initial 30 minutes of 
reoxygentaion attenuated mitochondrial membrane hyperpolarization.  
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Figure 2-2: IRL modulates mitochondrial membrane 
potential and attenuates reperfusion injury in 
cultured neurons. A. Mitochondrial membrane potential 
(∆Ψm) during irradiation with 950 nm IRL (live cells using 
TMRM). B. ∆Ψm during the initial 30 min of 
reoxygenation after 1h O2/glucose deprivation [OGD]. 
Expressed data are mean values of 96 live cell 
fluorescent well readings *p < 0.05. C. % viability in 
control cells, cells subjected OGD, and cells exposed to 
OGD treated with either excitatory IRL (810 nm) or 
inhibitory IRL (750 nm and 950 nm) wavelengths; *p < 
0.05). From Sanderson. 
 
The effect of IRL on neuronal cell 
survival after exposure to simulated ischemia-
reperfusion was examined.  Cells were 
irradiated with IRL via fiber-optic light guides 
for the initial hour of reoxygenation and cell 
death was quantified using a Live/Dead cell 
viability assay 24 hours later.  A reduction in 
cell death was observed by irradiation with 
inhibitory IRL wavelength (750 nm and 950 nm) 
while the excitatory IRL wavelength (810 nm) 
was not protective (Figure 2-2 C).  These 
insights into the effect of IRL during simulated 
ischemia-reperfusion in vitro have laid the foundation for subsequent in vivo efficacy 
testing.  Accordingly, focus was directed to examining the preclinical efficacy of IRL 
using a rat model of adult global brain ischemia.    
1.3 IRL Therapy Initiated at the Onset of Reperfusion Attenuates CA1 
Hippocampal Damage Resulting from Global Brain Ischemia  
Initial examination of the neuroprotective effect of IRL was evaluated in a rat 
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model of adult global brain ischemia resulting from bilateral carotid-occlusion with 
hypotension [64, 176-180].  This model leads neuronal injury occurring specifically in 
populations of hippocampal CA1 neurons [5, 6].  These neurons are particularly 
sensitive to ischemic insults, and a near-complete loss is observed at 3-7 days after 
reperfusion [7, 8].  Consistent with previously published results using the rat model of 
adult global brain ischemia, untreated control animals had a significant loss of CA1 
hippocampal neurons 14 days after the injury (Figure 2-3).  Representative images of 
the CA1 hippocampus are shown in Figure 2-3 A, together with triple label 
immunofluorescence to detect neurons, microglia, and astrocytes.  Quantification of 
Figure 2-3: IRL treatment following 
global brain ischemia attenuates CA1 
hippocampal damage. A. CA1 
hippocampal damage. [bottom row] 10X 
image of Cresyl violet stained 
hippocampus [middle row] 40X 
magnification of CA1 hippocampus, [top 
row] Triple-label immuno-fluorescence for 
NeuN (red-neuron marker), Iba-1 (green-
microglia marker) and GFAP (astrocyte 
marker). [Left column] Sham-operated 
animal (Sham), [center column] 8 min 
global brain ischemia followed by 14 days 
reperfusion (GBI), [right column] GBI plus 
IRL treatment (GBI + 950nm). B. Neuron 
counts in the CA1 hippocampus (mean ± 
SEM; *p<0.05 compared to GBI). 
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Figure 2-4:  IRL treatment following global brain ischemia attenuates mitochondrial ROS 
production. A. MitoSOX® fluorescence. Nuclei labeled with DAPI and mitochondrial ROS was 
detected with MitoSOX® (red). [Left] sham-operated (Sham), [Center] global brain ischemia followed 
by 30 min of reperfusion (GBI), [Right] GBI plus IRL treatment (GBI + 950 nm). (B) Quantitation of red 
fluorescence  (*p<0.05). 
CA1 neuronal counts is shown in Figure 2-3 B.  When normalized to sham-operated 
animals, global brain ischemia resulted in an 88% reduction in viable pyramidal neurons 
and treatment with the CcO-inhibitory IRL wavelengths, 750 nm and 950 nm, 
significantly attenuated CA1 hippocampal damage when used alone or in combination 
(Figure 2-3 B).  Treatment with the CcO-excitatory IRL wavelength, 810 nm, had no 
effect on neuronal viability in CA1 hippocampus.   
1.4 IRL Therapy Initiated at the Onset of Reperfusion Attenuates Mitochondrial 
ROS Production within CA1 Hippocampal Neurons 
In vitro studies outlined above suggest that inhibition of CcO at the onset of 
reperfusion is associated with a favorable reduction in mitochondrial ROS generation.  
To detect mitochondrial ROS generation in vivo, the fluorescent indicator MitoSOX® 
was used [181].  This colorless probe accumulates in mitochondria and becomes a red 
fluorescent dye upon oxidation.  By pretreating rats with MitoSOX® via intra-carotid 
artery infusion, the effect of IRL treatment on mitochondrial ROS production was 
examined microscopically.  As shown in Figure 2-4, inhibition of CcO at the onset of 
reperfusion was successful in attenuating mitochondrial ROS production following 
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cerebral ischemia.  Representative fluorescent image overlays of the CA1 hippocampus 
are shown in Figure 2-4A.  Consistent with the proposed model, global brain ischemia 
resulted in a significant increase in MitoSOX® fluorescence 30 minutes after the onset 
of reperfusion when compared to non-ischemic sham-operated controls (Figure 2-4 B).  
Furthermore, this increase in MitoSOX® fluorescence was abrogated in rats treated with 
IRL (Figure 2-4 B).  
2. Summary 
These data provide evidence of the preclinical efficacy of IRL therapy for the 
treatment of cerebral ischemia-reperfusion injury.  As demonstrated above, treatment 
with IRL wavelengths shown to reversibly inhibit CcO activity and reduce ∆Ψm in vitro 
significantly improved neuronal survival after global brain ischemia in the adult rat.  
Furthermore, IRL treatment initiated at the onset or reperfusion attenuated 
mitochondrial ROS production.  Thus, this therapeutic approach may provide a novel 
means of neuroprotection by circumventing mitochondrial ROS-mediated cell death 
signaling cascades. 
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CHAPTER 3 
Modeling Neonatal Hypoxic-ischemic Encephalopathy in the Rat 
1. Rationale  
The robust neuroprotective effect of IRL observed in the rat model of adult global 
brain ischemia described in Chapter 2 demonstrates the utility of this treatment for 
cerebral reperfusion injury.  The specific goal of my dissertation is to investigate the 
preclinical efficacy of this novel treatment paradigm in the neonatal brain – in 
particular,brain injuries arising as a result of perinatal asphyxia.  As a critical first step in 
achieving this goal, Chapter 3 focuses on the evaluation and refinement of a widely 
used animal model of neonatal hypoxic-ischemic encephalopathy (HIE).  
The ‘Vannucci’ rodent model of neonatal HIE is a commonly employed method 
based on the Levine preparation where unilateral common carotid artery ligation 
followed by systemic hypoxia produces significant injury in the hypoxic-ischemic 
cerebral hemisphere [182].  During the insult, systemic blood pressure and cerebral 
blood flow ipsilateral to the carotid artery ligation are reduced by approximately 25%. 
Although patency of the cerebral vasculature is maintained, hypoxia-ischemia results in 
a drastic reduction in cerebral perfusion owing to a loss in the cerebral vessel’s 
autoregulatory capacity.  Accordingly, ipsilateral to the carotid artery ligation cerebral 
perfusion pressure is reduced in proportion to the decline in systemic blood pressure. 
Following cerebral hypoxia-ischemia in the neonatal rat, morphologic and 
biochemical analysis indicate that both necrotic and apoptotic events occur which 
ultimately contribute to cerebral infarction [84, 116].  The apoptotic pathways activated 
following hypoxia-ischemia likely converge on caspase-3, which can be activated by the 
intrinsic or extrinsic pathways [183].  As described in Chapter 1, under normal 
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conditions mitochondrial ROS formation and degradation is balanced, thus, maintaining 
overall mitochondrial redox stability.  During reperfusion following cerebral hypoxia-
ischemia, mitochondrial ROS accumulate which likely promote apoptotic cell death by 
enhancing mitochondrial permeability leading to intrinsic activation of caspase-3 
following the release of mitochondrial cytochrome c [184, 185]. 
The specific biochemical phenotype and extent of cerebral infarction in the rodent 
model of neonatal HIE varies considerably from laboratory to laboratory and across 
animal strains.  Factors such as litter size and rodent diet, as well as the temperature 
during and duration of the hypoxic insult contribute significantly to the model’s severity 
and variability.  The broad distribution in the extent of brain injury produced by this 
model mandates that a large number of animal subjects be enrolled in a given study in 
order to demonstrate any treatment effect [186].  The experiments described here 
sought to evaluate the utility of the Vannucci rat model of neonatal HIE for use in our 
laboratory by (i) establishing the extent of variability in cerebral injury achieved, as well 
as (ii) determining the major biochemical conduit activated to promote cell death.  
2. Materials and Methods 
2.1 Reagents 
All reagents were purchased from Sigma Aldrich (St. Louis, MO) unless indicated 
otherwise. 
2.2 Animal Surgical Procedure.   
Rat pups of either sex were subjected to HIE on postnatal day 7 using the Vannucci 
model [182].  Briefly, pregnant female Sprague-Dawley rats were maintained in a 
temperature controlled environment with a 12hr light/dark cycle and were allowed to 
give birth naturally.  To minimize variability in feeding and body weight, litters were size-
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culled to 10 pups on postnatal day 3.  On postnatal day 7, pups were anesthetized 
using isoflurane (3.0% induction, 1.5% maintenance) in NO2/O2 (1:1).  The right 
common carotid artery was exposed via ventral midline neck incision and cut between 
double ligatures of 6.0 silk suture.  Sham operated control animals underwent the entire 
surgical procedure except for ligation and cutting of the carotid artery.  The incision was 
sutured and pups were returned to their dam to recover for 60min before being exposed 
to systemic hypoxia.  
2.3 Hypoxia Chamber Design  
Precise control of temperature during the hypoxic insult is critical in order to 
minimize the variability in cerebral injury.  Accordingly, a custom designed hypoxia 
apparatus was constructed.  The inner chamber consisted of a 2.8 L polypropylene 
container with an airtight removable lid equipped with a rubber gasket into which inlet 
and exhaust ports were drilled.  The inlet was connected to the glass barb of a 1L 
Büchner flask via a 30 cm long section of polyethelene tubing with an internal diameter 
of 0.635 cm.  The inner chamber and Büchner flask were submerged in a Plexiglas 
outer water bath (21L) with dimension of 33.3 cm (w) x 25.4 cm (h) x 45.7 cm (l) and a 
wall thickness of 6mm (VWR Internationa; Radnor, PA).  During the insult, gas 
containing 8% O2 (balanced in N2) was bubbled through the Büchner flask containing 
750 mL of dH2O which served to warm and humidify the gas.  Gas flow was maintained 
at a rate of 2.5 L/min.  Inner chamber air temperature was monitored using a t-type 
digital thermocouple (Physitemp Instruments; Clifton, NJ).  The outer water bath 
temperature was controlled by a submerged circulating water heater (Thermo Scientific; 
Waltham, MA) and the water temperature was set to 36.2oC or 35.0oC to achieve an 
inner chamber air temperature of 36.0±0.5oC or 34.5±0.5oC, respectively.  
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Figure 3-1: Custom designed hypoxia apparatus. The apparatus consists of an inner chamber (1), gas 
humidifier (2), water bath (3), and circulating water heater (4). Arrows indicate direction of gas flow.   
2.4 Hypoxic Insult  
After recovering from the carotid artery ligation surgery, pups were exposed to a 
constant flow of humidified 8.0% ± 0.1% oxygen balance in nitrogen (AirGas USA; 
Lansing, MI) in the custom-designed temperature-controlled chamber described above.  
The effect of hypoxia chamber temperature was evaluated by maintaining chamber air 
temperature at 34.5oC or 36.0oC and hypoxia was induced for 120 min or 180 min.    
2.5 Infarct Volume Analysis 
Forty-eight hours after the onset of reoxygenation, pups were euthanized via 
deep anesthesia with isoflurane.  Brain tissue was perfused transcardially with ice-cold 
phosphate buffered saline, pH 7.4.  Brains were removed and 1 mm coronal sections 
were cut using a vibratome (Campden Instruments;  Lafayette, IN).  Brain slices were 
immersed in 1% TTC in phosphate buffered saline, pH 7.4 and incubated at 37°C for 8 
minutes [187].  Next, the slices were fixed in 4% paraformaldehyde overnight in the 
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dark.  Finally, TTC stained sections were scanned and (i) area of infarction (unstained 
area), (ii) area of the ipsilateral hemisphere, and (iii) area of the contralateral 
hemisphere were quantified using Quantity One ® software (Biorad).  The percent 
infarcted area of each slice was determined by dividing the area of infarction (unstained 
area) by the area of the ipsilateral hemisphere of each slice and infarct volume was 
expressed as a percent of the ipsilateral hemisphere by summing the slices.  
2.6 Subcellular Fractionation 
To examine the effect of HIE on mitochondrial cytochrome c release and 
caspase 3 activation, subcellular fractions were obtained from injured and sham-
operated control animals using differential centrifugation for subsequent analysis via 
western blot.  At the indicated time points following the onset of reoxygenation, animals 
were transcardially perfused with ice-cold PBS and ipsilateral (hypoxia-ischemia) and 
contralateral (hypoxia-only) hemispheres were homogenized on ice in mitochondrial 
Isolation buffer (HEPES 25mM; pH7.7, Sucrose 250mM, KFl 10mM, Vanadate 1mM, 
EGTA 5mM, EGTA 2mM,  PMSF 0.1mM).  Following an initial centrifugation at 1000g 
for 10 min at 4oC, the supernatant was centrifuged at 16,700g for 20min at 4oC to 
isolate the crude mitochondrial fraction (pellet) and crude cytosolic fraction 
(supernatant).  For sham-operated controls, animals were sacrificed 5 hours after the 
initial surgery (time-matched to 120 min reoxygenation).   
2.7 Gel Electrophoresis and Immunoblotting 
The protein concentration of mitochondrial and cytosolic fractions was 
determined using the method described by Bradford  [188] and 50 μg of protein was 
loaded per lane and resolved via Tricine-SDS-PAGE as previously described [189].  
Each gel was then transferred to a nitrocellulose membrane that was blocked with 5% 
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nonfat dry milk in Tris-buffered saline containing 0.1% Tween 20.  Membranes were 
incubated over night at 4oC with primary antibodies against cytochrome c (BD 
Biosciences, San Jose, CA), cleaved caspase 3, VDAC, and GAPDH (Cell Signaling 
Technology, Boston, MA).  With the exception of anti-cleaved caspase 3, which was 
diluted 1:500, all primary antibodies were diluted 1:1000.  Bands were visualized using 
horseradish peroxidase-conjugated secondary antibodies (Sigma-Aldrich, St Louis, MO) 
and the scanned and digitalized films were analyzed using Quantity One ® software 
(Biorad).  Cytochrome c and cleaved caspase 3 immunoreactivity was normalized to 
GAPDH or VDAC to control for protein loading of cytosolic and mitochondrial fractions, 
respectively. 
2.8 Statistical Analysis 
All data were compared using Prism software (Graphpad; La Jolla, CA) and are 
presented as means ± SEM.  Following a test for normality, a one-way ANOVA was 
performed and pairwise post-hoc comparisons were made using the Newman–Keuls 
method.  Infarct data from the 120 min hypoxic insult were not normally distributed; 
accordingly, these data were analyzed using a Kruskal–Wallis one-way ANOVA by 
ranks followed by Dunn’s post hoc analysis. P-values < 0.05 were considered 
statistically significant. 
3. Results 
3.1 Hypoxia-ischemia Results in Substantial Infarction 
In accordance with previous studies employing this model, rat pups subjected to 
unilateral common carotid artery ligation followed by exposure to 8% oxygen sustained 
cerebral infarction ipsilateral to the carotid artery ligation (Figure 3-2).  Importantly, 
neither  hypoxia  nor carotid ligation  alone  produced a  discernible  injury.  Infarction 
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Figure 3-2: Hypoxia-ischemia results in substantial
cerebral infarction. Postnatal day 7 rats were subjected to
unilateral carotid artery ligation and subsequent hypoxia (8%
O2 balanced in N2; 180 min). Forty-eight hours after the onset
of reperfusion, brains were sliced and stained with TTC (Red=
viable tissue; unstained regions = infarction) 
primarily affects the cerebral cortex, however involvement of subcortical regions 
including the basal ganglia was also observed.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
3.2 Temperature and Duration of the Hypoxic Insult Influence Mortality and Infarct 
Severity in the Neonatal Rat Model of HIE   
A total of 54 and 38 rat pups were enrolled to undergo 120 and 180 minutes of 
hypoxia at 36C, with an additional 43 and 56 animals subjected to hypoxia at 34.5C.  
Mortality following the shorter, 120 minute hypoxic insult was negligible (<3.7%), 
irrespective of temperature (Figure 3-3 A).  However, in animals assigned to receive 
180 minutes of hypoxia, mortality was greater in animals maintained at 36C versus 
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34.5C (36.8% versus 3.6%; Figure 3-3-A). 
Figure 3-3. Temperature and duration of a hypoxic insult affect infarct volume and mortality. B. 
Infarct volume expressed as a percent of the ipsilateral hemisphere measured 48 hours after cerebral 
hypoxia-ischemia in the neonatal rat. Median infarct volume resulting from 180 minutes of hypoxia was 
significantly greater than that caused by 120 minutes at chamber temperatures of 36.0oC and 34.5oC 
(*P<0.05). Notably, chamber temperature had no significant effect on median infarct volume. A. 
Comparison of % mortality for 120 and 180 minute hypoxic insults at chamber temperatures of 36.0oC 
and 34.5oC.   
Among survivors, ipsilateral median infarct volume resulting from 180 minutes of 
hypoxia was significantly greater than that caused by 120 minutes regardless whether 
the hypoxia chamber temperature was maintained at 36.0oC or 34.5oC (Figure 3-3 B).  
Importantly, and in contrast to results obtained with 120 minutes of hypoxia, all animals 
developed detectable (albeit variable) areas of infarction.   
3.3 Cytosolic Accumulation of Cytochrome c is Associated with Increased 
Caspase 3 Activation during Early Reperfusion Following Cerebral Hypoxia-
Ischemia in the Neonatal Rat  
Cytosolic accumulation of cytochrome c leads to activation of caspase-3 via the 
intrinsic pathway resulting in apoptotic cell death.  Accordingly, our next objective was to 
determine whether this pathway is activated in the neonatal rat brain following a 180 
minute hypoxic insult at 34.5°C – the conditions identified in Section 4.2 to consistently 
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yield infarction with minimal mortality.  To address 
this issue, cytosolic fractions obtained from ipsilateral 
(hypoxic-ischemic) and contralateral (hypoxia-only) 
hemispheres were collected at the end of hypoxia-
ischemia, as well as following 30 and 120 minutes of 
reoxygenation (n=4-5 replicates per time-point).  
Sham-operated animals time-matched to 120 min 
reoxygenation were used as controls (n=4).  As 
shown in Figure 3-4, western blot analysis revealed a 
significant increase in cytochrome c accumulation 
within the cytosolic fraction following 120 minutes of 
reperfusion in the ipsilateral hemisphere (*P<0.05 
versus sham).  Importantly, increased cytosolic 
cytochrome c was not observed in the ipsilateral 
hemisphere at earlier time points of reperfusion, nor 
was increased cytosolic cytochrome c detected in the 
contralateral hemisphere.  
As shown in Figure 3-5 western blot analysis 
of the catalytic cleavage of caspase 3 indicates that 
this proapoptotic cysteine protease is activated 
acutely in the brain, following hypoxia-ischemia in the 
neonatal rat.  Detection of cleaved caspase 3 within 
the cytosol of the ipsilateral hemisphere was possible as early as 30 minutes following 
the onset of reperfusion in two animals; and after 120 minutes of reperfusion all animals 
Figure 3-4: Cytosolic accumulation of
cytochrome c following cerebral
hypoxia-ischemia in the neonatal rat.
A. Representative immunoblot for
cytochrome c and GAPDH in the
cytosol. Cytochrome c accumulation
was normalized to GAPDH, and
averaged data (mean ± SEM) are
shown for sham-operated control, at the
end of hypoxia-ischemia, as well as
following 30 or 120 min of reperfusion
from ipsilateral (B) and contralateral (C)
hemispheres. (*P<0.05)   
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tested showed cleaved caspase 3 immunoreactivity confined to the ipsilateral 
hemisphere.  
 
4. Summary  
Consistent with previously published literature, the extent of cerebral injury 
produced by this rodent model of HIE was variable.  Hypoxia chamber temperature had 
an impact on mortality, but did not significantly change infarct volume with equal hypoxic 
duration.  These findings demonstrate the critical importance of maintaining a suitable 
chamber temperature during the hypoxic insult when using this model.  The duration of 
the hypoxic event also influenced both the consistency of developing cerebral infarction 
and median infarct volume, with larger infarcts observed with insults lasting 180 versus 
120 minutes.  While shorter hypoxic insults have been utilized in a small number of 
studies by other groups [84, 190], pilot studies using 60 and 90 minutes of hypoxia 
conducted using the chamber described above yielded no detectable infarct via TTC 
staining 48 hours after the insult.  
Figure 3-5: Activation of caspase 3 following
cerebral hypoxia-ischemia in the neonatal rat. A.
Representative immunoblot for cleaved caspase 3
(17kd) and GAPDH in the cytosol. B. Cleaved
caspase 3 immunoreactivity was normalized to
GAPDH, and averaged data (mean ± SEM) are
shown for sham-operated control (Sham), at the end
of hypoxia-ischemia (End), as well as following 30 or
120 min of reperfusion from the ipsilateral
hemisphere. (*P<0.05)   
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Although, the distribution of ipsilateral infarct volumes among animals subjected 
to either 120 or 180 minutes of hypoxia was broad, the longer hypoxic duration led to 
infarct detection in all animals.  Accordingly, a hypoxic insult of 180 minutes in duration 
was chosen for use in examining mitochondrial permeability, cytosolic accumulation of 
cytochrome c and activation of caspase 3.  To this end, hypoxia-ischemia, but not 
hypoxia alone, led to significant cytosolic accumulation of cytochrome c within 2 hours 
following the onset of reperfusion which was associated with caspase 3 activation.  
Consequently, using a hypoxic duration of 180 minutes and a chamber temperature of 
34.5oC, these findings suggest that the rat model of neonatal HIE causes mitochondrial 
permeability transition and ultimately leads to the induction of apoptosis which, 
presumably, contributes to the cerebral infarction observed.  
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CHAPTER 4 
Cardiolipin Oxidation and Hydrolysis in Neonatal HIE: Development and 
Application of a Novel Mass Spectrometry Method  
1. Rationale 
Cardiolipins (CL) [bis-(1,2-diaceyl-sn-glycero-3-phospho)-1’-3’-sn-glycerols] form 
a unique class of anionic phospholipid found nearly exclusively within the inner 
mitochondrial membrane in eukaryotic cells.  CL influences a wider variety of 
fundamental functions including mitochondrial inner membrane curvature [191] and 
OxPhos supercomplex formation [192, 193].  Cleavage of CL by phospholipase A2 
(PLA2) isoforms yields monolysocardiolipin (MLCL), which along with oxidized CL has 
been implicated in apoptotic signaling and cell death [107, 194].    
In adult rat models of acute traumatic brain injury and cerebral ischemia-
reperfusion, mitochondrial CL was observed to be selectively oxidized [195, 196].  
Ongoing work by Kagan and collogues suggests that CL-oxidation occurs following the 
transfer of electrons directly from reduced cytochrome c and newly oxidized CL is 
hydrolyzed by calcium-independent PLA2 activity to form MLCL and oxidized free fatty 
acids [196, 197].  This chapter focuses on: i) the development of a novel mass 
spectrometry (MS) method for use in interrogating the integrity of mitochondrial CL; and 
ii) the application of this method to investigate the effect of cerebral hypoxia-ischemia 
on CL oxidation and hydrolysis using the neonatal rat model of HIE described in 
Chapter 3. 
2. Traditional Mass Spectrometry for the Analysis of Phospholipids 
Commonly, MS platforms used to study membrane phospholipids, including CL, 
are coupled to high-performance liquid chromatography and, more recently, to thin-layer 
chromatography [198].  While the enrichment effect of chromatographic separation is 
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often necessary when lipids of extremely low abundance are the targets for analysis, 
these techniques require significant expertise and, importantly, introduce perturbations 
arising from the extraction and separation conditions used.  Accordingly, ionization 
methods for use in MS that enable lipid extraction to be avoided altogether are 
emerging for use in lipid research [199-207].  
Membrane phospholipids, including CL, are typically studied in the negative ion 
mode using electrospray ionization (ESI) and matrix-assisted laser desorption/ionization 
(MALDI)-MS.  MALDI produces predominantly singly charged [M-H]- CL ions, whereas 
ESI readily generates abundant doubly charged [M-2H]2- CL ions.  ESI and MALDI are 
considered to be ‘soft’ ionization methods, and MALDI is particularly important for 
membrane lipid research applications because of its ability to ionize phospholipid 
species directly from intact biological membranes and tissues without prior lipid 
extraction [205].  Conversely, ESI is invaluable in lipidomics applications because of its 
ease of coupling with liquid chromatography [208] and its multiple charging which 
enhances the utility of ion mobility spectroscopy (IMS) and MS/MS applications.   
Recently, alternative ‘soft’ ionization processes have been discovered for use in 
MS that combine strengths of both ESI and MALDI.  Specifically, desorption-ESI (DESI) 
and laserspray ionization (LSI) readily generate multiply charged lipid ions and have 
been successfully used analyze phospholipids directly from the surface of tissue slices 
without lipid extraction [199, 209].  While substantial progress has been made using 
these novel ‘soft’ ionization methods in platforms for lipid research, their reliance on 
high-tech lasers or electrospray sources necessitates a reasonably high degree of skill 
for successful implementation.  Conversely, matrix-assisted ionization (MAI) is a 
recently described ‘soft’ ionization method capable of generating multiply charged ions 
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[210-212].  The production of gas-phase ions is achieved through MAI matrix 
sublimation upon exposure of the matrix/analyte crystalline solid to the vacuum, 
inherent to mass spectrometers [212].  Owing to the sublimation-driven mechanism 
underlying ion formation by MAI, there is no need for external energy input in the form of 
laser ablation, electrospray voltages, or heat [212].   
Within the last decade, ion mobility spectrometry (IMS)-MS has become an 
important analytical method in lipid research with IMS providing an additional dimension 
of gas-phase separation, analogous to liquid chromatography.  For complex lipid 
mixtures like those found in the biological membranes, IMS-MS yields two-dimensional 
separation in a timescale of a few milliseconds [213, 214].  Unlike high performance 
liquid chromatography or thin layer chromatography, IMS provides real-time gas-phase 
separation as ions travel through an ion-mobility cell, allowing lipid classes and 
subclasses to be separated based on radial acyl chain length, degree of unsaturation 
and head group variance [206, 207, 214].  Both ESI and MALDI have been successfully 
coupled to IMS for lipid analysis; however, ionization methods that readily generate 
multiply charged ions are more ideally suited for use in multidimensional IMS-MS 
applications [213].  Additionally, given that IMS separation occurs in the gas-phase 
following ionization, its use is amenable to research applications focused on studying 
lipids from intact membranes where liquid-phase chromatography is unachievable.  
The experiments described here, conducted in collaboration with Sarah Trimpin, 
PhD (Department of Chemistry), sought to evaluate the use of MAI-IMS-MS as a 
method for the characterization of CL species directly from intact mitochondrial 
membranes.  The success of this work is largely due to the recent discovery of a novel 
MAI matrix, 1,2-dicyanobenzene (DCB).  Using DCB, the Trimpin laboratory has 
49 
 
achieved MAI-MS sensitivities as low as 5 fmol with purchased cardiolipin standards 
which is far superior to the sensitivities observed using the well-studied MAI matrix, 3-
Nitrobenzonitrile (3-NBN).   
3. Technical Development of the MAI-IMS-MS Method 
3.1 Materials and Methods 
3.1.1 Reagents 
All reagents were purchased from Sigma Aldrich (St. Louis, MO) unless indicated 
otherwise. 
3.1.2 Mitochondrial Isolation 
Technical development of the MAI-IMS-MS method development and 
characterization of the MS spectra was performed using mitochondria isolated from 
naïve (nonischemic) heart, liver and brain of female retired breeder Sprague Dawley 
rats.  Briefly, tissue was homogenized on ice in mitochondrial Isolation buffer (Hepes 
25mM; pH7.7, Sucrose 250mM, EGTA 5mM, EGTA 5mM).  Following an initial 
centrifugation at 1000g for 10 min at 4oC, the supernatant was centrifuged at 16,700g 
for 20min at 4oC to isolate the crude mitochondrial fraction (pellet).  Mitochondria were 
diluted to a protein concentration of 1mg•mL-1 in 20:80 H2O:EtOH containing 0.1% 
NH4OH. 
3.1.3 Matrix Assisted Ionization – Ion Mobility Spectrometry – Mass Spectrometry  
The MAI matrix DCB (Alfa Aesar;  Ward Hill, MA) was dissolved in acetonitrile 
(5mg in 50µL) and mixed with enriched mitochondrial samples (1:1,v/v).  Immediately 
prior to analysis, the solution containing matrix and mitochondria was drawn into a pipet 
tip in 1µL aliquots and allowed to crystallize at the end of the tip. As previously 
described [210-212], samples were introduced directly into the vacuum of the mass 
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spectrometer by placing the pipet tip against the skimmer cone inlet.  Mass spectra 
were obtained using a Waters SYNAPT G2 quadrupole-TOF and ion mobility 
spectrometry was performed with N2 as the ion mobility gas.   
3.2 Results 
3.2.1 Multidimensional MAI-IMS-MS Analysis of Mitochondrial Cardiolipin  
The MAI matrix DCB performed well in the presence of mitochondrial isolation 
buffer with minimal chemical background, and no appreciable effect on ion abundance, 
charge state or ion adduction was observed in the negative mode.  Figure 4-1c shows a 
two-dimensional plot of ion mobility drift time vs. mass-to-charge (m/z) ratio obtained 
from rat brain mitochondria via MAI-IMS-MS.  Molecular ions fall along two clearly 
  
discerned trend lines determined by charge state where singly charged [M-H]- ions have 
longer drift times compared to doubly charged [M-2H]2- ions.  As seen in Figure 4-1a, 
the mass spectra obtained from rat brain mitochondria is complex, and significant 
Figure 4-1: MAI-IMS-MS of rat
brain mitochondria. Mass
spectra of a) rat brain
mitochondria and b) doubly
charged [M-2H]2- MLCL and CL
species extracted using IMS drift
time. c) Two-dimensional plot of
IMS drift time vs. m/z.
Multidimensional IMS-MS
analysis enables doubly charged
[M-2H]2- and singly charged [M-
H]- ions to be cleanly separated.
The zoomed spectra highlight
the extensive isotopic
overlapping of doubly charged
[M-2H]2- and singly charged [M-
H]- ions which is eliminated
through the use of IMS drift time
deconvolution.   
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overlapping of singly charged [M-H]- phospholipid ions with the doubly charged [M-2H]2- 
CL ions occurs between m/z 650-850.  Deconvolution using IMS drift time enables the 
mass spectrum of the doubly charged [M-2H]2- monolysocardiolipin (MLCL) and CL ions 
to be easily extracted (Figure 4-1b) from the two-dimensional plot.  
 
As anticipated, gas phase lipid ions generated during MAI matrix sublimation 
yield ESI-like fragmentation spectra during tandem MS using  collision-induced 
dissociation (CID).  The fragmentation spectra of tetra-linoleoyl-cardiolipin (Avanti Polar 
Lipids; Alabaster, AL) obtained using MAI-, ESI- and MALDI-MS/MS were compared 
(data not shown).  Independent of the ionization method used, characteristic 
monoacylglycerol phosphate, diacylglycerol phosphate, and fatty acid fragment ions 
Figure 4-2:  MAI-IMS-MS/MS characterization of cardiolipin species from brain mitochondria. a)
MAI-IMS-MS/MS spectra of the doubly charged [M-2H]2- CL precursor ion at m/z 749.5 from rat brain
mitochondria. Fatty acid fragment ions ([FA]-) at m/z 253.2, 281.2, 303.2 and 327.2 correspond to
palmitoleic (C16:1), oleic (C18:1), arachidonic (C20:4) and docosahexaenoic (C22:6) acids, respectively.
Monoacylglycerol phosphate ([MGP]-) fragment ions are observed at m/z 389.2, 417.2, 439.2, and 436.2.
Doubly charged [M-2H]2- triacyl-monolyso-cardiolipin fragment ions ([MLCL]2-) formed from the neural
loss of a ketene, and singly charged [M-2H]- triacyl-monolyso-cardiolipin fragment ions ([MLCL]-) are also
observed. b) Two-dimensional plot of IMS drift time vs. m/z showing two precursor ions at m/z 749.5 with
distinct IMS drift times were selected in the quadrupole and subjected to CID fragmentation. Using IMS
drift time, fragment ions originating from the doubly charged [M-2H]2- CL precursor ion with a drift time of
5.86 milliseconds (white box)  are cleanly separated from those originating from the singly charged [M-
H]- precursor ion with a drift time of 9.26 milliseconds.  
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were observed.  Additionally, the doubly charged [M-2H]2- CL precursor ions generated 
by MAI and ESI, yielded a doubly charged [M-2H]2- triacyl-monolyso-cardiolipin 
fragment ion resulting from the neutral loss of a ketene. 
MAI-IMS-MS/MS characterization of CL species from mitochondrial samples is 
achieved using IMS drift time as an additional dimension by which precursor ions 
selected in the quadrupole can be isolated.  Figure 4-2 shows the MAI-IMS-MS/MS 
fragmentation spectrum generated during CID fragmentation of the doubly charged [M-
2H]2- CL precursor ion at m/z 749.5 of rat brain mitochondria.  As observed in the 2-
dimensional plot, two ions with distinct IMS drift times were selected in the quadrupole 
at m/z 749.5.  Using IMS drift time, fragment ions origination from the doubly charged 
[M-2H]2- CL precursor ion with a drift time of 5.86 milliseconds are cleanly separated 
from those origination from the singly charged [M-H]- precursor ion with a drift time of 
9.26 milliseconds.  
Another noteworthy utility of IMS-MS is the rapid means of determining relative 
abundance ratios using the drift time peak area.  Consequently, the relative ratio of any 
two lipid classes or subclasses, separated in the two-dimensional plot, can be easily 
determined.  Figures 4-3, 4-4 and 4-5 show the mass spectra of the major CL species 
observed in rat heart, liver and brain mitochondria, respectively.  The various acyl-
groupings of CL are clustered based on the overall carbon content of their four acyl 
chains.  The relative contribution of each acyl-grouping to the total CL pool was 
determined using drift time.  To do this, the drift time peak area for each acyl-grouping 
was divided by the total CL peak area.  These data are compared in Table 4-1.  
In accordance with previously published results using traditional MS platforms 
[215, 216], the diversity of mitochondrial CL species detected using MAI-IMS-MS was 
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tissue- dependent.  The major CL species observed in the heart and liver were 
composed of four 18-carbon acyl-chains.  In the heart mitochondria this accounted for 
81.3% of the total CL pool and was exclusively tetra-linoleoyl-cardiolipin (723.5 m/z; 
CL72:8). In the liver mitochondria both tetra-linoleoyl-cardiolipin (723.5 m/z; CL72:8) as 
well as tri-linoleoyl-mono-oleoyl-cardiolipin (724.5 m/z; CL72:7) were detected which 
together comprised 53.1% of the total CL pool.  The CL profile of brain mitochondria 
contained more CL species than either the heart or liver mitochondria, and many of the 
brain CL species were comprised of long acyl chains including arachidonic (C20:4) and 
docosahexaenoic (C22:6) acids. 
 
Figure 4-3: MAI-IMS-MS spectra of the cardiolipin content of rat heart mitochondria. The enlarged 
spectra highlight the isotopic distribution within each acyl-grouping.  
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Figure 4-4: MAI-IMS-MS spectra of the cardiolipin content of rat liver mitochondria. The enlarged 
spectra highlight the isotopic distribution within each acyl-grouping.  
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Figure 4-5: MAI-IMS-MS spectra of the cardiolipin content of rat brain mitochondria. The enlarged 
spectra highlight the isotopic distribution within each acyl-grouping. 
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Table 4-1: Relative contribution of major cardiolipin Acyl-groupings observe in isolated 
mitochondria 
 
4. Application of the Method in the Neonatal HIE Model 
4.1 Materials and Methods 
4.1.1 Induction of Cerebral Hypoxia-ischemia 
Using MAI-IMS-MS, as described above, we next sought to determine whether 
cerebral hypoxia-ischemia influenced the overall mitochondrial CL profile.  Neonatal rat 
pups of either sex were subjected to HIE on postnatal day 7 using the Vannucci model 
[182].  As described in chapter 3, pups were anesthetized using isoflurane (3.0% 
induction, 1.5% maintenance) in NO2/O2 (1:1) and the right common carotid artery was 
exposed via ventral midline neck incision and cut between double ligatures of 6.0 silk 
sutures.  Sham operated control animals underwent the surgical procedure except for 
ligation and cutting of the carotid artery.  The incision was sutured and pups were 
returned to their dam to recover for 60 min before being exposed to a constant flow of 
humidified 8% oxygen balance in nitrogen in the custom-designed temperature-
(mean ± s.d.) (mean ± s.d.) (mean ± s.d.)
CL 68:x not detected 3.7% ± 0.5% 1.2% ± 0.5%
CL 70:x 2.1% ± 0.2% 13.7% ± 2.1% 4.9% ± 0.9%
CL 72:x 81.3% ± 7.6% 53.1% ± 3.2% 5.1% ± 1.2%
CL 74:x 6.1% ± 1.8% 16.2% ± 3.2% 20.2% ± 3.2%
CL 76:x 4.9% ± 0.5% 6.8% ± 1.8% 21.8% ± 5.5%
CL 78:x not detected 6.4% ± 0.4% 16.3% ± 0.6%
CL 80:x not detected not detected 11.3% ± 0.9%
CL 82:x not detected not detected 5.6% ± 0.8%
CL 84:x not detected not detected 2.8% ± 0.1%
CL 86:x not detected not detected 1.1% ± 0.2%
CL 88:x not detected not detected 0.5% ± 0.1%
Acyl-Grouping
Heart 
Mitochondria 
Liver 
Mitochondria
Brain 
Mitochondria
% of Total Cardiolipin Peak Area
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controlled chamber described in chapter 3.  Chamber air temperature was maintained at 
34.5oC and hypoxia was induced for 180 min.  
Using the methods described in Section 2.1.2, mitochondria were isolated from 
ipsilateral (hypoxic-ischemic) and contralateral (hypoxia-only) cerebral hemispheres at 
the end of hypoxia-ischemia, as well as following 30 and 120 minutes of reoxygenation.  
Sham-operated animals time-matched to 120 min reoxygenation were used as controls. 
MAI-MS-MS was performed as detailed in Section 2.1.3 and interrogated as in Section 
2.1.1. 
4.1.2 Statistical Analysis 
MLCL:CL ratios were determined by integration of extracted drift time curves to 
yield a peak area for CL and MLCL.  The MLCL peak area was divided by the CL peak 
area to obtain an MLCL:CL ratio.  These data were then analyzed using Prism software 
(Graphpad; La Jolla, CA) and are presented as means ± SEM.  A one-way ANOVA was 
performed and pair wise post-hoc comparisons were made using the Newman–Keuls 
method.   
4.2 Results 
4.2.1 Cerebral Hypoxia-ischemia Increases the MLCL:CL Ratio  
As shown in Figure 4-6, hypoxia-ischemia resulted in a significant increase in the 
MLCL:CL ratio during early reperfusion.  Importantly, the increased MLCL:CL ratio was 
observed exclusively in the ipsilateral hemisphere (hypoxic-ischemic), while in the 
contralateral hemisphere (hypoxia-only) the ratio remained unchanged following the 
insult and throughout reoxygenation (Figure 4-7).    
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Figure 4-6: Cerebral hypoxia-ischemia leads to an increased ratio of MLCL:CL in mitochondria 
following reoxygentation. a) Representative mass spectra of the doubly charged [M-2H]2- MLCL and CL 
species observed in mitochondria of the ipsilateral cerebral hemisphere from a sham-operated control 
animal [top row], an animal exposed the hypoxia-ischemia [middle row], and an animal exposed to 
hypoxia-ischemia followed by 30 minutes of reperfusion [bottom row]. b) Extracted drift-time curves of 
MLCL (4.78ms) and CL (5.68ms) from sham-operated control [top row], hypoxia-ischemia [middle row], 
and hypoxia-ischemia + 30 minutes of reperfusion [bottom row]. c) An MLCL:CL ratio of each 
mitochondrial sample, was determined by dividing  MLCL peak area by the CL peak area. Averaged data 
(mean ± SEM) are shown for sham-operated control (Sham), at the end of hypoxia-ischemia (End), as 
well as following 30 or 120 min of reperfusion. (*P<0.05)  
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Figure 4-7: Cerebral hypoxia has no effect on mitochondrial MLCL:CL ratio. a) Representative mass 
spectra of the doubly charged [M-2H]2- MLCL and CL species observed in mitochondria of the 
contralateral cerebral hemisphere from a sham-operated control animal [top row], an animal exposed the 
hypoxia [middle row], and an animal exposed to hypoxia followed by 30 minutes of reoxygenation [bottom 
row]. b) Extracted drift-time curves of MLCL (4.78ms) and CL (5.68ms) from sham-operated control [top 
row], hypoxia [middle row], and hypoxia + 30 minutes of reoxygenation [bottom row]. c) An MLCL:CL ratio 
of each mitochondrial sample, was determined by dividing  MLCL peak area by the CL peak area. 
Averaged data (mean ± SEM) are shown for sham-operated control (Sham), at the end of hypoxia (End), 
as well as following 30 or 120 min of reoxygenationn. (*P<0.05)  
5. Summary 
5.1 Technical Advantages of the Method 
The central role of membrane lipids in impacting cellular and subcellular 
physiology is becoming more and more apparent; therefore, the ability to identify, 
quantify and characterize membrane lipids directly from their native and intact biological 
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membranes is of vital importance.  While ESI is easily coupled to liquid chromatography 
and is widely used in full-scale lipidomic studies, MALDI remains an attractive method 
for many membrane lipid research applications because of its ability to ionize 
phospholipid species without prior lipid extraction.  MAI is a newly described ionization 
method that provides a novel means of combining many of the strengths of ESI and 
MALDI for use in studying membrane phospholipids.  Unlike ESI and MALDI, where 
significant technological knowledge is necessary for successful experimentation, MAI is 
operationally simple and does not require the use of a laser or electrospray source.  
Thus, MAI is compatible with a wide array of commercially available mass 
spectrometers, requiring only the application of a MAI matrix such as 3-NBN or DCB.   
5.2 Insights into Neonatal HIE 
This work represents significant progress made in applying MAI-MS for the study 
of the membrane phospholipid, CL, from intact and native mitochondrial membranes.  
When used in conjunction with IMS-MS, this ionization method also provides a rapid 
and effective means of obtaining the biologically significant MLCL:CL ratio through 
analysis of extracted IMS drift time curves.  Using this MAI-IMS-MS approach, cerebral 
hypoxia-ischemia in the neonatal rat was shown to result in a significant increase in the 
MLCL:CL ratio during early reperfusion.  
While CL hydrolysis during cerebral ischemia-reperfusion may occur 
enzymatically following CL oxidation via PLA2 [217], it should be noted that in the 
current study, no appreciable CL oxidation was detected using MAI-IMS-MS.  
Subsequent MAI-IMS-MS/MS studies should be conducted to address this using an 
untargeted screen for oxidized fatty acyl fragment ions arising from doubly charged [M-
2H]2- CL ions between m/z 650-850.  Chemically, however, CL hydrolysis during 
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ischemia-reperfusion may occur as a result of nucleophilic catalysis directly, and to this 
end, acid catalyzed CL hydrolysis has been reported [218, 219].  Independent of the 
underlying mechanism, an increase in the MLCL:CL ratio is highly suggestive of 
increased mitochondrial free radical production.   
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CHAPTER 5 
Preclinical Evaluation of Infrared Light Therapy Using a Rat Model of Neonatal 
Hypoxic-ischemic Encephalopathy 
1. Rationale 
As presented in Chapter 2, evidence of the preclinical efficacy of IRL therapy for 
the treatment of cerebral ischemia-reperfusion injury was initially obtained using a rat 
model of adult global brain ischemia.  Treatment with two IRL wavelengths shown to 
reversibly inhibit CcO activity and reduce ∆Ψm in vitro (750 nm and 950 nm) 
significantly improved survival of CA1 hippocampal neurons after global brain ischemia 
in the adult rat while, in contrast, treatment with the CcO-excitatory IRL wavelength, 810 
nm, had no effect on neuronal viability in CA1 hippocampus.  Additionally, when initiated 
at the onset of reperfusion, treatment with the CcO-inhibitory IRL wavelength, 950 nm, 
attenuated mitochondrial superoxide production.  These findings provide direct support 
for the overarching hypothesis that reversible inhibition of CcO during early reperfusion 
reduces mitochondrial ROS production and in turn confers neuroprotectection.  The 
experiments described here sought to evaluate the efficacy of this novel treatment 
paradigm using the neonatal rat model of HIE characterized in the preceding two 
chapters of this dissertation.  
2. Materials and Methods 
2.1 Reagents 
All reagents were purchased from Sigma Aldrich (St. Louis, MO) unless indicated 
otherwise. 
2.2 Induction of Cerebral Hypoxia-ischemia 
Neonatal rat pups of either sex were subjected to HIE on postnatal day 7 using 
the Vannucci model [182].  As described in Chapter 3, pups were anesthetized using 
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isoflurane (3.0% induction, 1.5% maintenance) in NO2/O2 (1:1) and the right common 
carotid artery was exposed via ventral midline neck incision and cut between double 
ligatures of 6.0 silk sutures.  The incision was sutured and pups were returned to their 
dam to recover for 60 min before being exposed to hypoxia (i.e., a constant flow of 
humidified 8% oxygen balanced in nitrogen) in the custom-designed temperature-
controlled chamber described in Chapter 3.  Chamber air temperature was maintained 
at 34.5oC and hypoxia was induced for 180 min. 
2.3 Administration of IRL Treatment 
At the onset of reoxygenation, rat pups were immobilized by securing them to the 
surface of 50 mm x 75 mm glass slides using laboratory tape, and animals were 
transferred to a dry-air incubator (Thermo) held at 35.0oC. IRL was administered by 
direct illumination through the skull via a LED device placed 5 cm from the dorsal scalp 
(Figure 5-1).  IRL treatment was conducted using low power, single-wavelength LED 
diodes (Roithner Lasertechnology) emitting light with a wavelength of 750, 810, or 950 
nm. IRL irradiation was initiated at the onset of reoxygenation and was continued for 
120 min.  
 
  
Figure 5-1: IRL administration. A. 
Postnatal day 7 rat pup immobilized for IRL 
treatment using a 50mm x 75mm glass slide 
and laboratory tape. B. IRL emmiting LED 
device equipped with single wavelength 
diodes (Roithner Lasertechnology). C. IRL 
administration of rat pups via direct 
illumination of the skull using the LED 
device.  
64 
 
2.4 Infarct Volume Analysis 
Infarct volume was determined 48 hours after the onset of reoxygenation via TTC 
staining of the coronally sectioned brain and infarct volume was expressed as a percent 
of the ipsilateral hemisphere as described in Section 2.5 of Chapter 3.  
2.5 Subcellular Fractionation 
Mitochondrial and cytosolic fractions were obtained 120 minutes following the 
onset of reoxygenation from animals treated with IRL (750 nm) as well as from non-
treated controls.  Subcellular fractionation was achieved using differential centrifugation 
as described in Section 2.6 of Chapter 3. Briefly, both the ipsilateral (hypoxia-ischemia) 
and contralateral (hypoxia-only) hemispheres were homogenized on ice in mitochondrial 
Isolation buffer (HEPES 25mM; pH7.7, sucrose 250mM, KFl 10mM, vanadate 1mM, 
EGTA 5mM, EGTA 2mM, PMSF 0.1mM). Following an initial centrifugation at 1,000g for 
10 min at 4oC, the supernatant was centrifuged at 16,700g for 20min at 4oC to isolate 
the crude mitochondrial fraction (pellet) and crude cytosolic fraction (supernatant).  
2.6 Gel Electrophoresis and Immunoblotting 
The effect of IRL on HIE- induced accumulation of cytochrome c within the 
cytosol and activation caspase 3 was evaluated using the western blotting technique 
described in Section 2.7 of Chapter 3. Briefly, 50 μg of cytosolic protein was loaded per 
lane and resolved via Tricine-SDS-PAGE. Primary antibodies against cytochrome c (BD 
Biosciences, San Jose, CA), cleaved caspase 3, and GAPDH (Cell Signaling 
Technology, Boston, MA) were used. With the exception of anti-cleaved caspase 3, 
which was diluted 1:500, all primary antibodies were diluted 1:1000. Bands were 
visualized using horseradish peroxidase-conjugated secondary antibodies (Sigma-
Aldrich, St Louis, MO) and the scanned and digitalized films were analyzed using 
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Quantity One ® software (Biorad).  
2.7 Matrix Assisted Ionization – Ion Mobility Spectrometry – Mass Spectrometry  
The effect of IRL treatment on the mitochondrial MLCL:CL ratio was evaluated 
via MAI-IMS-MS as described in Section 3.1.3 of Chapter 4. Mitochondria were 
obtained 120 minutes following the onset of reoxygenation from IRL-treated animals 
and non-treated controls, and were diluted to a final protein concentration of 1mg•mL-1 
in 20:80 H2O:EtOH containing 0.1% NH4OH. The MAI matrix DCB (Alfa Aesar;  Ward 
Hill, MA) was dissolved in acetonitrile (5mg in 50µL) and mixed with enriched 
mitochondrial samples (1:1,v/v). Immediately prior to analysis, the solution containing 
matrix and mitochondria was drawn into a pipet tip in 1µL aliquots and allowed to 
crystallize at the end of the tip. As previously described in Chapter 4, samples were 
introduced directly into the vacuum of the mass spectrometer by placing the pipet tip 
against the skimmer cone inlet. Mass spectra were obtained using a Waters SYNAPT 
G2 quadrupole-TOF and ion mobility spectrometry was performed with N2 as the ion 
mobility gas.   
3. Results 
3.1 IRL Therapy Initiated at the Onset of Reperfusion Reduces Cerebral Infarct 
Volume Following Hypoxia-ischemia in the Neonatal Rat 
A total of 63 rat pups were enrolled to evaluate the effect of IRL treatment 
following hypoxia-ischemia.  Pups were randomly assigned to receive 120 min of IRL-
treatment with a wavelength of 750, 810, or 950 nm (n=15, 15 and 16, respectively). 
Non-treated littermates served as sham controls (n=17).  
As shown in Figure 5-2, treatment with the CcO-inhibitory IRL wavelength, 750 
nm, as well as the CcO-excitatory IRL wavelength, 810 nm, significantly attenuated 
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cerebral infarction resulting from neonatal hypoxia-ischemia: mean infarct volumes were 
31.3% and 29.0%, versus the value of 48.9% seen in untreated sham controls.  
Treatment with the 950 nm IRL wavelength resulted in a mean infarct volume of 34.3% 
which approached, but did reach, significance (p=0.127) when compared with controls.   
 
Figure 5-2: IRL treatment attenuates cerebral infarction  resulting from hypoxia-ischemia in the 
neonatal rat. Postnatal day 7 rats were subjected to unilateral carotid artery ligation and subsequent 
hypoxia (8% O2 balanced in N2; 180 min). Animals were randomly assigned to receive 120 min of IRL-
treatment with a wavelength of 750, 810, or 950 nm. Non-treated littermates served as controls. Forty-
eight hours after the onset of reperfusion, brains were sliced and infarct volume was assessed. A. 
Representative TTC stained brain slices from a non-treated control and an IRL-treated animal (750 nm). 
Red= viable tissue; unstained regions = infarction. B. Mean infarct volume for all IRL treatments as well 
as non-treated controls (*p<0.05).  
 
3.2 IRL Treatment Attenuates caspase 3 Activation during Early Reperfusion 
Following Cerebral Hypoxia-ischemia in the Neonatal Rat 
As demonstrated in Chapter 3, the neonatal rat model of HIE results in 
mitochondrial permeability, cytosolic accumulation of cytochrome c  and activation of 
caspase 3 in the ipsilateral (hypoxic-ischemic) hemisphere within 2 hours following the 
onset of reperfusion.  Furthermore, using MAI-IMS-MS, cerebral hypoxia-ischemia in 
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Figure 5-3: Effect of IRL treatment on cytosolic
accumulation of cytochrome c and caspase 3
cleavage following cerebral hypoxia-ischemia in the
neonatal rat. A. Representative immunoblot for
cytochrome c, cleaved caspase 3, and GAPDH in the
cytosolic fraction obtained from the ipsilateral hemisphere
of IRL-treated and non-treated animals (control) subjected
to hypoxia-ischemia. Cytochrome c accumulation and
caspase 3 cleavage were normalized to GAPDH, and
averaged data (mean ± SEM) are shown for control and
IRL treated (750 nm) for cytochrome c (B) and cleaved
caspase 3 (C). (*P<0.05)   
the neonatal rat was also shown to result in a significant increase in the mitochondrial 
MLCL:CL ratio during early reperfusion (Chapter 4).  Thus, we next sought to examine 
whether the attenuation in cerebral infarction seen in the neonatal rat with IRL treatment 
was associated with favorable reductions in mitochondrial cardiolipin hydrolysis, 
mitochondrial permeability and caspase 3 cleavage. 
Cytosolic fractions obtained from ipsilateral (hypoxic-ischemic) and contralateral 
(hypoxia-only) hemispheres were collected from non-treated and IRL-treated animals 
following 120 minutes of reoxygenation (n=4 per group).  The wavelength of 750 nm 
was used for IRL treatment, and irradiation was 
initiated at the onset of reoxygenation and 
maintained until the time of sacrifice (120 min).  
Figure 5-3 shows the results of western blot 
analysis of cytosolic cytochrome c accumulation 
and caspase 3 cleavage in the ipsilateral 
(hypoxic-ischemic) hemisphere of IRL-treated 
and non-treated control animals. No difference in 
cytosolic cytochrome c accumulation was 
observed between IRL-treatment and control 
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(Figure 5-3 A).  However, cleavage of caspase 3 was nonetheless attenuated by 
treatment with IRL (Figure 5-3 B).  As anticipated, no differences in cytosolic 
cytochrome c accumulation or caspase 3 cleavage were observed in the non-injured 
contralateral hemisphere between IRL-treated and non-treated control animals (data not 
shown).  
Using the MAI-IMS-MS approach described in Chapter 4, the effect of IRL on the 
mitochondrial MLCL:CL ratio following hypoxia-ischemia was investigated.  
Mitochondria were obtained from the ipsilateral (hypoxic-ischemic) hemisphere of non-
treated and IRL-treated (750 nm) animals following 120 minutes of reoxygenation (n=4 
per group).  Given that the mitochondrial MLCL:CL ratio was previously found to be 
unchanged in the contralateral (hypoxia-only) hemisphere using this rat model of 
neonatal HIE (Chapter 4), the current study focused exclusively on the ipsilateral 
(hypoxic-ischemic) hemisphere.  Figure 5-4 A shows the mass spectra of the doubly 
charged [M-2H]2- MLCL and CL species observed in mitochondria of the ipsilateral 
cerebral hemisphere of a non-treated control animal as well as an animal treated with 
IRL (750 nm) for 120min.  The MLCL:CL ratio was determined by integration of the 
extracted drift time curves for CL and MLCL, and the MLCL peak area was divided by 
the CL peak area.  Using this method, no significant difference in the MLCL:CL ratio 
was observed between IRL-treatment and control (Figure 5-4 C).  
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4. Summary 
Consistent with results from previous IRL efficacy studies using a rat model of 
adult global brain ischemia, IRL treatment using the CcO-inhibitory IRL wavelength, 750 
nm, attenuated cerebral injury resulting from hypoxia-ischemia in the neonatal rat.  
Furthermore, 750 nm IRL initiated at the onset of reperfusion, attenuated caspase 3 
cleavage.  
Experiments in the current chapter did, however, yield unexpected observations.   
First, in contrast to data obtained in the adult rat model of global brain ischemia 
(Chapter 2), treatment with the CcO-excitatory wavelength, 810 nm, reduced ipsilateral 
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Figure 5-4: Mitochondrial MLCL:CL ratio following cerebral
hypoxia-ischemia is unaffected by IRL treatment. A.
Representative mass spectra of the doubly charged [M-2H]2- MLCL
and CL species observed in mitochondria of the ipsilateral cerebral
hemisphere from a non-treated control animal [top row] and an
animal treated with IRL (750 nm) for 120min [bottom row]. B.
Extracted drift-time curves of MLCL (4.78ms) and CL (5.68ms) from
control [top row] and IRL-treatment [bottom row]. C. Averaged data
(mean ± SEM) from control and IRL-treatment (750 nm); n=4 per
group. 
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infarct volume in the neonate model.  One potential explanation for this surprising result 
is that alternative and as-yet unexplored mechanisms of neuroprotection may be elicited 
by IRL therapy in the neonatal model of cerebral ischemia-reperfusion when compared 
to the previously studied adult model.  These alternative mechanisms may work in 
conjunction with, or independent of, the hypothesized mechanism of mitochondrial 
modulation by CcO.  To this end, a divergence of CcO isoform expression within 
mitochondria of the neonatal and adult brain may – in part – explain the discrepancy in 
observations between the two studies.  CcO isoform switching has been described in 
lung mitochondria where CcO subunit IV isoforms 1 and 2 are preferentially expressed 
in the immature and mature lung, respectively [220].  Future studies should evaluate the 
effect of these specific IRL wavelengths (750, 810 and 950 nm) on CcO isolated from 
neonatal brain mitochondria to determine how exactly neonatal CcO activity responds to 
IRL irradiation in vitro.  
It is also surprising that although neuroprotective, treatment with 750 nm IRL in 
the current study had no effect on the mitochondrial MLCL:CL ratio as measured by 
MAI-IMS-MS.  Previous in vitro and in vivo studies using this CcO-inhibitory IRL 
wavelength support the hypothesis that 750 nm IRL treatment attenuates mitochondrial 
ROS production during early reperfusion following ischemia (Chapter 2).  As suggested 
in Chapter 4, the mitochondrial MLCL:CL ratio may serve as an intrinsic indicator of 
mitochondrial ROS production as CL hydrolysis to form MLCL likely occurs directly as a 
result of – or enzymatically following – the production of mitochondrial ROS. 
Nonetheless, using MAI-IMS-MS no detectable difference was observed in the 
MLCL:CL ratio following cerebral ischemia-reperfusion between 750 nm IRL-treatment 
and non-treated control.  Similarly, no detectable difference in cytosolic cytochrome c 
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accumulation was observed between IRL-treatment and control.  Subsequent studies 
should be conducted to verify this initial observation and additional delayed time points 
following the onset of reperfusion should be considered.  It is possible that difference in 
these and/or other biochemical outcomes may become more apparent between IRL-
treatment and control as the cerebral injury evolves.  
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CHAPTER 6 
Discussion 
1. Summary of Results 
Ongoing work from the Hüttemann and Sanderson laboratories has provided the 
fundamental mechanistic rationale for the use of IRL therapy as a treatment for cerebral 
reperfusion injury.  The preclinical success of this approach stems from a 
comprehensive understanding of the role of mitochondria in cell death caused by 
cerebral ischemia-reperfusion injury.  As summarized in Chapter 1, a model has been 
proposed in which ischemic alterations of mitochondrial OxPhos primes the 
mitochondria for subsequent reperfusion-induced ∆Ψm hyperpolarization leading to a 
burst in mitochondrial ROS generation and loss of mitochondrial function.  These 
mitochondrial alterations ultimately culminate in delayed neuronal death following the 
release of proapoptotic factors from the mitochondria into the cytosol.  This progression 
is simplified into four main states that summarize the induction, progression, and 
execution of cell death during brain ischemia-reperfusion: 1) ischemic starvation (i.e., 
ETC is rendered non-functional by the lack of O2); 2) reperfusion-induced 
hyperactivation; 3) mitochondrial dysfunction; and 4) delayed neuronal death (Chapter 
1, Figure1-2).  
As discussed in Chapter 2, specific wavelengths of IRL can directly modulate 
CcO activity. IRL with a wavelength of 750nm or 950nm was found to inhibit CcO 
activity, while 810 nm IRL was found to modestly increased CcO activity (Chapter 2; 
Figure 2-1).  Given that CcO catalyses the final, and proposed rate limiting step in 
mitochondrial electron transfer – the donation of electrons to O2 – modulation of CcO 
activity via irradiation with IRL provides a novel mean of non-invasively regulating 
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electron flux through the ETC and, by extension, the overall ∆Ψm.  Treatment with IRL 
wavelengths shown to inhibit CcO activity in vitro was associated with a favorable 
reduction in mitochondrial ROS generation when initiated at the onset of reperfusion 
following global brain ischemia in the adult rat and resulted in significant neuroprotection 
(Chapter 2).  
The overarching goal of this dissertation was to investigate the preclinical 
efficacy of this novel treatment paradigm in the neonatal brain – in particular, brain 
injuries arising as a result of perinatal asphyxia. Ischemic insults to the infant brain most 
often result from prolapse or compression of the umbilical cord during delivery and 
placental abruption [16-18].  Because these injuries are generally sustained while in a 
hospital setting at the time of delivery, this patient population is much more likely to 
receive therapeutic intervention early following the onset of reperfusion.  Given that 
∆Ψm hyperpolarization and mitochondrial ROS production likely occur rapidly following 
the onset of reoxygenation, treatment of asphyxiated infants with IRL may provide a 
non-invasive means of attenuating cerebral injury in this patient population.  
The goal of the work described in Chapters 3 and 4 was to examine the utility of 
the Vannucci rat model of neonatal HIE for use in the preclinical evaluation of IRL 
therapy.  Consistent with previously published literature, the extent of cerebral injury 
produced by this rodent model of neonatal HIE was variable.  Not surprisingly, the 
duration of the hypoxic event influenced both the consistency of cerebral infarction and 
the median infarct volume.  However, maintenance of a suitable chamber temperature 
during the hypoxic insult was also demonstrated to be critical.  Experiments reported in 
Chapter 3 established that mitochondrial permeability, cytosolic accumulation of 
cytochrome c and activation of caspase 3 were manifest acutely following cerebral 
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hypoxia-ischemia, but not hypoxia-alone.  Additionally, using the MAI-IMS-MS approach 
described in Chapter 4, cerebral hypoxia-ischemia, but not hypoxia-alone, was shown to 
result in a significant increase in the MLCL:CL ratio during early reoxygenation.  This 
latter observation is highly suggestive of mitochondrial ROS production, as CL 
hydrolysis to form MLCL occurs directly as a result of (or enzymatically following) the 
production of mitochondrial ROS.  Taken together: although the inherent variability in 
injury severity of this animal model necessitates that a large number of animal subjects 
be enrolled in a given study in order to demonstrate any treatment effect, the acute 
biochemical phenotype produced by HIE appears to progress in accordance with 
predictions outlined in Chapter 1.  Specifically, mitochondrial ROS production and 
mitochondrial permeability occur acutely following the onset of reoxygenation and 
precede the activation of apoptosis.   
Consistent with results from previous IRL efficacy studies using the adult global 
brain ischemia, IRL treatment using the CcO-inhibitory IRL wavelength of 750 nm 
attenuated cerebral injury resulting from hypoxia-ischemia in the neonatal rat.  
Furthermore, IRL at 750 nm, initiated at the onset of reperfusion, attenuated caspase 3 
cleavage.  Unexpectedly, however, in contrast to data obtained in the adult rat model of 
global brain ischemia, treatment with the CcO-excitatory wavelength, 810 nm, also 
reduced ipsilateral infarct volume in the neonate model.  As described in Chapter 5, one 
potential explanation for this surprising result is that alternative responses to IRL 
therapy may exist in the neonatal brain when compared to the mature brain. 
2. Technical Limitations and Future Directions 
One major limitation of this work stems from the inherent variability of cerebral 
injury produced by this rat model of neonatal HIE.  Despite the significant effort invested 
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in optimization, cerebral infarct size among untreated controls ranged from a minimum 
of 17.9% to a maximum of 83.5% of the ipsilateral hemisphere.  This substantial 
variation confounds both the ability to identify therapies that will have a meaningful 
effect on infarct size, and, as discussed below, yield mechanistic insights into these 
therapies.  Future preclinical studies investigating the optimal IRL wavelength and/or 
wavelength combinations as well as the overall safety of this therapeutic approach 
should be conducted in a large animal model.  
Another significant limitation is that the mitochondrial MLCL:CL ratio has not 
been validated empirically as an intrinsic indicator of mitochondrial ROS production.  
While CL hydrolysis to form MLCL likely occurs directly as a result of (or enzymatically 
following) the production of mitochondrial ROS, it is conceivable that this process may 
occur enzymatically via a calcium-dependent PLA2 simply as a result of the 
mitochondrial calcium loading that likely occurs during ischemic starvation (see Chapter 
1 Section 3).  Ongoing work using isolated mitochondria seeks to address this 
possibility in an attempt to better interpret the physiological significance of an increased 
MLCL:CL ratio following cerebral ischemia-reperfusion.    
As described in Chapter 5, using MAI-IMS-MS no detectable difference was 
observed in the MLCL:CL ratio following cerebral ischemia-reperfusion between 750 nm 
IRL-treatment and non-treated control.  Similarly, no detectable difference in cytosolic 
cytochrome c accumulation was observed between IRL-treatment and control.  Given 
the inherent variability in injury severity produced by this model, it is possible that these 
unanticipated observations are merely the result of insufficient sampling (n=4 per 
group), and that had a larger number of animals been enrolled (e.g. n =15-20 per 
group), a treatment effect would have been detected.  This explanation (under-
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sampling) is strengthened further if a linear relationship is assumed to exist between 
early biochemical outcomes (mitochondrial MLCL:CL ratio and cytosolic cytochrome c 
accumulation) and cerebral infarct volume measured 48 hours after the onset of 
reperfusion.  Subsequent studies should be conducted to address this limitation.  
Finally, the current study focused exclusively on biochemical events occurring 
acutely following the onset of reperfusion while injury severity was assessed 48 hours 
later.  Future studies would benefit from adding additional endpoints at delayed time 
points, as it is possible that pathophysiological and/or treatment-induced effects are 
occurring as the cerebral injury evolves. 
3. Conclusions 
This work has provided two major technical contributions to the field of cerebral 
ischemia-reperfusion injury.  First, experiments in Chapter 3 have refined and provided 
biochemical characterization of the rat model of HIE.  Second, Chapter 4 focused on the 
development of a method of characterizing membrane lipids directly from their native 
and intact biological membranes without prior lipid extraction using the MAI-MS 
technology pioneered in the Trimpin laboratory.  While the current study used this new 
method exclusively to investigate alterations in the CL profile of brain mitochondria 
following cerebral hypoxia-ischemia, the approach can be employed in various 
membrane lipid research applications.  Finally, consistent with results from previous IRL 
efficacy studies using a rat model of adult global brain ischemia, experiments in Chapter 
5 establish that IRL treatment attenuated cerebral injury resulting from hypoxia-ischemia 
in the neonatal rat.  Thus, and perhaps most importantly, this work contributes to the 
development of a potential novel therapeutic approach in the management of brain 
injuries arising as a result of perinatal asphyxia. 
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ABSTRACT 
PRECLINICAL EVALUATION OF INFRARED LIGHT THERAPY IN A RAT MODEL 
OF NEONATAL HYPOXIC-ISCHEMIC ENCEPHALOPATHY 
by 
CHRISTIAN ANDREW REYNOLDS 
August 2015 
Advisor: Drs. Karin Przyklenk and Thomas Sanderson 
Major: Physiology 
Degree: Doctor of Philosophy 
This work has provided two major technical contributions to the field of cerebral 
ischemia-reperfusion injury.  First, experiments in Chapter 3 have refined and provided 
biochemical characterization of the rat model of HIE.  Second, Chapter 4 focused on the 
development of a method of characterizing membrane lipids directly from their native 
and intact biological membranes without prior lipid extraction using the MAI-MS 
technology pioneered in the Trimpin laboratory.  While the current study used this new 
method exclusively to investigate alterations in the CL profile of brain mitochondria 
following cerebral hypoxia-ischemia, the approach can be employed in various 
membrane lipid research applications.  Finally, consistent with results from previous IRL 
efficacy studies using a rat model of adult global brain ischemia, experiments in Chapter 
5 establish that IRL treatment attenuated cerebral injury resulting from hypoxia-ischemia 
in the neonatal rat.  Thus, and perhaps most importantly, this work contributes to the 
development of a potential novel therapeutic approach in the management of brain 
injuries arising as a result of perinatal asphyxia. 
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